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Every nucleated cell has a defined morphology to cater to the needs of its unique 
function. To generate polarity during growth, budding yeast Saccharomyces cerevisiae transports 
all necessary organelles into the bud. This transport requires the essential myosin V motor, 
Myo2. Using different cargo receptors, Myo2 transports secretory vesicles, mitochondria, 
vacuoles and other cargoes. A conditional mutant myo2-66 in particular fails to transport 
secretory vesicles. Initially discovered as a multicopy suppressor of myo2-66, Smy1 suggested 
the involvement of a kinesin motor for transport of secretory vesicles. However, because 
suppression does not need either kinesin motor activity or an interaction with microtubules, 
the function of Smy1 remained elusive.  
Here I show that kinesin-related Smy1 stabilizes the association between Myo2 and the 
secretory vesicle receptor, the Rab GTPase Sec4. Smy1 function is specific for secretory vesicle 
transport. Characterization of Smy1 individual domains indicates that full length Smy1 is 
required since the head domain is important for vesicle association and the tail domain for 
Myo2 binding. Furthermore, I used a GAL1 cDNA library to suppress a conditional myo2 smy1 
mutant as a way to identify additional components that may function in secretory vesicle 
transport. One novel component we identified has a RhoGAP domain in its C-terminus, so I 
named it GYM1 (GAP with Yeast Myo2). I found that Gym1 is polarized to the bud and its 
localization is dependent on Myo2. Further, biochemical assays showed that Gym1specifically 
stimulates the GTPase activity of Rho3 and mutation of its critical arginine at residue 546 
abolishes this activity. Genetic analysis also showed that the ability of Gym1 to suppress the 
myo2 smy1 mutant requires the GAP activity towards Rho3. In mammalian cells, TC10 Rho 
proteins are also reported to mediate vesicle transport. This new finding of Rho3 and its 
associated GAP, Gym1 in budding yeast suggests that there is an interplay between Rho and 
Rab GTPases in secretory vesicle transport.  
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Chapter I 
 
Introduction to the historical emergence of budding yeast as a model organism 
 
Budding yeast, Saccharomyces cerevisiae, came a long way to become a model organism for 
scientific research in laboratory. Yeast has been used traditionally in brewing beers by 
fermenting sugars, and raising bread dough by releasing carbon dioxide, hence as the name 
implies – baker’s yeast (Greig and Leu, 2009). Yeast is naturally found in vineyards and people 
have used crushed grapes in a variety of food processing (Mortimer, 2000). It was not until the 
late 1800s that Carlsberg laboratory employee Emil Christian Hansen isolated single colonies 
from a starter culture; from that time on, scientific experiments on yeast have ensued 
(Mortimer and Johnston, 1986). By using modern microscopy, baker’s yeast was found to 
undergo a budding process during cell division and it became known as budding yeast, in 
contrast to fission yeast, Schizosaccharomyces pombe.  
 
The budding yeast strain, S288C, that is used most widely, was first constructed in 
1950 (Mortimer and Johnston, 1986). Many more strains were eventually created by genetic 
modifications. In 1996, with the effort of the international scientists’ community, budding 
yeast set the milestone for the first-ever complete eukaryotic genome (Goffeau et al., 1996). 
Budding yeast has 16 chromosomes and 6604 protein-encoding genes or ORFs (Open Reading 
Frames) as of September, 2016 (http://www.yeastgenome.org/genomesnapshot). Out of 6604 
ORFs, 78% (5155) were verified and their functions have been characterized. The functions of 
the remaining ORFs have been identified as more and more scientists have investigated yeast 
genetics.  
 
Due to its high similarity to the DNA sequence of humans and similar functional 
homology between mammalian and yeast cells, budding yeast has been a workhorse for many 
scientists for discovering, investigating and understanding the intricate mechanisms of cells 
(Botstein et al., 1997; Kataoka et al., 1985). Budding yeast has been used as a model organism 
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for investigating cell division, DNA damage and repair, chromosome organization, 
transcription regulation, stress response, membrane trafficking, vesicle transport and more 
(Dekker et al., 2002; Greig and Leu, 2009; Hartwell et al., 1970; Lydall and Weinert, 1995; 
Novick et al., 1980). 
 
The pinnacle of significant discovery was made when Lee Hartwell elucidated steps in 
cell cycle regulation in budding yeast and that the regulation was almost the same as in 
humans (Hartwell et al., 1970). Because disruption of some CDC genes (Cell Division Cycle) 
leads to cancer in humans, Lee Hartwell was awarded Nobel Prize in 2001 for his discovery of 
cell cycle regulation. Another stepping stone in understanding structures of the components 
critical for DNA transcription was also made in budding yeast by Roger Kornberg who later 
received the Nobel Prize in 2006 (Kornberg, 1974). Budding yeast also contributed to 
understanding vesicle trafficking and for this work, Randy Schekman received the Nobel prize 
in 2013 (Novick et al., 1980; Novick and Schekman, 1979). As of this writing in 2016, budding 
yeast contributed another Nobel laureate, Yoshinori Ohsumi, who developed an understanding 
of the cellular mechanism for self-eating which is also known as autophagy (Takeshige et al., 
1992; Tsukada and Ohsumi, 1993). As a model organism, budding yeast has served as the envy 
of scientists and it has contributed an immense amount to our knowledge of cell biology.  
 
Budding yeast – an excellent model for cell polarity 
 
Budding yeast has been an excellent model for studying molecular processes that 
include establishment of cell polarity, inheritance of parental mitochondria, vacuoles or 
lysosomes, mRNA migration, biogenesis of proteins in the endoplasmic reticulum (ER), 
endocytosis, exocytosis and membrane trafficking (Botstein et al., 1997). Much progress 
toward understanding the basic cellular processes have therefore come from studies of budding 
yeast.  
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Figure 1.1
Vegetative growth
cycle nutrient deprivation
sporulation
shmoo projections
zygote
diploid a/α
haploid a haploid α
haploid a or α
Pseudohypal growth
Mating 
Cell Wall
Plasma membrane
Actin patch
Actin cable
Actin ring
Nucleus
Figure 1.1. Life cycle of budding yeast in different conditions.
Vegatative growth cycle represents the growth cycle of either a haploid cell (mating type a or α) or a diploid cell (a/α). Cells undergo a 
budding process until a septin ring composed of actin filaments constricts the division between mother and daughter cells. Mating 
condition happens when two haploid cells with opposite mating types are grown together. Budding yeast under certain nutrient 
deprivation undergo pseudohyphal growth at the tip. 
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Budding yeast in nature is diploid. It undergoes meiosis under nutrient stress to form 
haploid spores in tetrads (Figure 1.1). Haploid cells can maintain either of two mating types (a 
or α). Budding yeast has three distinctive morphologies during its vegetative growth, mating 
and filamentous growth (Gimeno and Fink, 1994; Madden et al., 1992). Vegetative growth 
begins with an emergence of a small bud at the cell cortex and subsequently polarized growth 
ensues at the site of the bud. Cytokinesis, which is facilitated by contractile ring constriction at 
the bud neck, later ends the polarized growth, which generates two cells. On the other hand, 
during mating, haploid cells assume a pear-shaped morphology known as a “shmoo” formation, 
which facilitates the contact between two opposite mating cells. Budding yeast under certain 
types of nutrient deprivation also undergoes pseudohyphal growth at the tip (Figure 1.1).  
 
The asymmetric growth of budding yeast therefore presents an excellent model to study 
mechanisms behind polarity establishment and a polarized growth (Pruyne and Bretscher, 
2000). In the late 1900s, a number of labs discovered many mechanisms and proteins that 
govern the budding process in Saccharomyces cerevisiae. Using conditional mutants, Schekman 
and his colleagues showed that secretory vesicles accumulate at the site of bud formation in 
certain mutants, which led to the first discovery of a defined secretory pathway for establishing 
polarity in budding yeast (Novick et al., 1980; Novick and Schekman, 1979).  
 
It was later found that yeast growth requires an essential myosin motor or Myo2 in 
budding yeast (Johnston et al., 1991). Adams and Pringle also showed that actin filaments, one 
of the cytoskeletons, were also polarized towards the site of growth and a cluster of actin 
patches were also found at the site of bud formation (Adams and Pringle, 1984). The first 
evidence, that Myo2 transports secretory vesicles along actin filaments, came from the analysis 
of the conditional actin-stabilizing mutant, tpm1-2 tpm2Δ (Pruyne et al., 1998). Further work 
from the Bretscher lab also showed that Myo2 tail was required for transporting secretory 
vesicles (Schott et al., 1999). Therefore polarity in budding yeast can be grouped into two main 
processes: (1) establishment of polarized actin filaments and (2) secretory vesicle transport and 
segregation of organelles by Myosin-V motors (Bretscher, 2003).  
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Polarized actin cytoskeletons 
 
Among the myriad of proteins involved in the budding process, actin, an essential 
protein, assembles into three distinct structures during growth: (1) actin cables (2) cortical 
actin patches and (3) an actin ring at the bud neck, which are essential for polarized exocytosis, 
endocytosis, and cytokinesis, respectively (Figure 1.1) (Adams and Pringle, 1984; Gallwitz and 
Seidel, 1980; Gallwitz and Sures, 1980; Lippincott and Li, 1998; Moseley and Goode, 2006). 
Actin (ACT1) and tubulins (TUB1, TUB2, and TUB3) make up the major cytoskeletal elements, 
and yet it was unclear initially whether both actin filaments and microtubules were required 
for bud formation. It was not until 1988, when Huffaker et al., used cold-sensitive tubulin tub2 
mutants, to show that microtubules are not required for secretory vesicle transport: instead, 
they are involved in nuclear migration (Huffaker et al., 1988). Using the microtubule 
depolymerizing agent, nocodazole, the Pringle lab also showed that microtubules were only 
required for nuclear migration and orientation (Jacobs et al., 1988).  
 
Not only has the importance of actin cables been characterized but a number of actin-
binding proteins were also identified. Sac6 (Fimbrin) was identified to be an actin-bundling 
protein (Adams et al., 1989). The actin stabilizing protein, tropomyosin Tpm1/2, was also 
discovered in the Bretscher lab (Liu and Bretscher, 1989). Capping protein (Cap2), Profilin 
(Pfy1), and Cofilin (Cof1) were later identified and characterized to regulate actin cables 
(Amatruda et al., 1990; Haarer et al., 1990; Moon et al., 1993). Actin binding protein (Abp1) 
was also found in cortical actin patches (Drubin et al., 1988).  
 
During the early 2000s, the molecular mechanisms behind the formation of actin cables 
and cortical patches were unraveled. Initially discovered as a RhoGTPase interacting protein, 
Bni1, which is localized at the bud, was found to be involved in bipolar budding (Zahner et al., 
1996). Bni1 is a member of a diaphanous related formins (DRF). DRF proteins have conserved 
FH domains (Formin Homology) that are implicated in cell polarity and actin organization.  
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Bni1 has a RhoGTPase binding domain (RBD) at its N-terminus and FH1 and FH2 
domains near its C-terminus. The FH1 domain of Bni1 recruits profilin, which binds actin 
monomer, and the FH2 domain nucleates actin assembly (Figure 1.2) (Evangelista et al., 2002; 
Pruyne et al., 2002; Sagot et al., 2002). A mutation in the FH2 domain, therefore, results in 
loss of the Bni1 function. Budding yeast has two formin homologues: Bni1 and Bnr1; these 
assemble actin cables at the apical bud and at the bud neck, respectively (Pruyne et al., 2004).  
 
Similar to actin nucleation for cable formation, several proteins were also identified to 
be involved in the formation of actin patches. The Arp2/3 complex, which is composed of 7 
subunits containing the major Actin-Related Proteins (Arp2 and Arp3), is crucial for cortical 
actin patch assembly and endocytosis (Goley and Welch, 2006; Kaksonen et al., 2003). 
Nucleation promoting factors (NPF) were later found to be necessary for actin assembly by the 
Arp2/3 complex, which rendered a new actin filament that branches 70˚ from the existing one. 
The majority of NPFs have a WH domain (Wiskott-Aldrich syndrome protein or WASP 
homology) that binds G-actin. Budding yeast has one WASP homologue: Las17 or Bee1 (Figure 
1.2) (Li, 1997; Madania et al., 1999).  
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Actin can assemble into either cables or patches during budding. To distinguish which 
structure is important for polarized growth, the Bretscher lab generated a conditional 
tropomyosin mutant, which is a protein that only localizes to the actin cables. They showed 
that polarized actin cables, rather than actin patches, were essential for transporting secretory 
vesicles by the myosin motor towards the site of bud emergence (Pruyne et al., 1998).  
 
RhoGTPase Cdc42 – Master regulator of cell polarity  
 
The small GTPase Rho proteins are involved in organization of the actin cytoskeleton 
and in establishment of the polarity. Yeast Cdc42 plays a central role in establishing polarity 
both in humans and in yeast. Because they have 85% sequence similarity, human Cdc42 can 
complement the yeast cdc42 mutant (Johnson and Pringle, 1990; Munemitsu et al., 1990). 
Cdc42 is necessary for bud site selection and it is associated with a scaffolding complex, which 
is generally composed of Bem1, Cdc42, Cdc24, and Cla4 (Bose et al., 2001). Cdc24 is the 
guanine nucleotide exchange factor (GEF) for Cdc42, that activates Cdc42 to the GTP bound 
state. Cla4, a Cdc42 effector and a p21-activated kinase (PAK) family member, activates Cdc24 
GEF by phosphorylation (Gulli et al., 2000). Activated Cdc24 further activates Cdc42-GTP 
which in turn binds to the scaffolding platform – Bem1, Cdc24, Cla4 – resulting in a positive 
feedback loop for Cdc42 activation. 
 
Cdc42 activates formin to initiate actin assembly at the cell cortex. Formins stay in the 
autoinhibitory state when their N-terminal DID (Diaphanous  Inhibitory Domain) interacts 
with C-terminal DAD (Diaphanous Autoregulatory Domain) (Figure 1.2) (Goode and Eck, 
2007). Binding of the RhoGTPase at the formin RhoGTPase binding domain (RBD) 
presumably opens up the profilin binding FH1 domain and facilitates the assembly of actin 
monomers at the FH2 domain. Budding yeast has six Rho GTPases (Rho1, Rho2, Rho3, Rho4, 
Rho5 and Cdc42). Cdc42, Rho1, and Rho3 physically interact with Bni1 and are purported to 
be prime activators of Bni1 activity in the bud. The polarisome complex, which is composed of 
Bni1, Spa2, Pea2 and Bud6, is involved subsequently in the formation of polarized actin cables 
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(Bi and Park, 2012). Cdc42 is proposed to undergo actin-based Myo2 motor transport towards 
the bud, which generates a positive feedback cycle of Cdc42-GTP clustering at the tip by 
subsequently recruiting more formin for actin assembly at the site of bud emergence (Bi and 
Park, 2012; Wedlich-Soldner et al., 2003). However, this model remains controversial with a 
new finding that Cdc42 polarizes in the bud with an actin-independent manner (Woods et al., 
2016).  
 
Myosin V motor : motor activity  
 
Myosins are a large family of actin-based motors. The myosin superfamily was first 
classified based on motor head domains. Later classification based on myosin tails also 
similarly corresponded to head domain classes (Thompson and Langford, 2002). Each class of 
myosin has distinct functions. Budding yeast has five myosin genes, two of which encode class 
V myosins (MYO2 and MYO4). Myo2 is responsible for delivery of secretory vesicles and 
segregation of organelles, whereas Myo4 transports Ash1 mRNA actively into the bud for 
determination of mating type (Haarer et al., 1994; Johnston et al., 1991; Schott et al., 1999). 
Myo1p (class II) is involved in actin ring constriction during cytokinesis at the bud neck (Bi, 
2001; Lippincott and Li, 1998). Endocytosis and cell wall biogenesis require Myo3 and Myo5 
(class I) (Bi, 2001; Goodson et al., 1996; Goodson and Spudich, 1995).  
 
One of the functions of Myo2 was first uncovered by studying the temperature-sensitive 
(ts) myo2-66 mutant (Johnston et al., 1991). Later work showed that Myo2 transports secretory 
vesicles to the bud tip without interfering with protein biosynthesis. The myo2-66 mutant has a 
profound effect on cell wall synthesis, which is evidenced by chitin delocalization, a major 
component in the cell wall. The mutant also showed a loss of vacuole inheritance (Hill et al., 
1996). Those earlier observations on the myo2 mutant indicated that Myo2 was involved in 
intracellular transport. Similarly, mammals have three isoforms of Class V Myosin (MyoVa, Vb, 
Vc); each are expressed differentially in different tissues. MyoVa is highly expressed in the 
brain, testis, and skin, and MyoVb and MyoVc are expressed primarily in epithelial cells 
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(Prekeris and Terrian, 1997; Reck-Peterson et al., 2000; Rodriguez and Cheney, 2002; 
Swiatecka-Urban et al., 2007). Studying mammalian MyoV and yeast Myo2 has resulted in an 
understanding of the molecular function of the myosin V motor. Myosin Vs have three distinct 
domains: (1) the motor head domain (2) the α-helical “neck” domain or the lever arm, and (3) 
the globular tail domain or cargo binding domain.  
 
The motor head domain  
 
MyoV undergoes substantial conformational changes in its motor head domain during 
actin-based transport. Unlike conventional muscle myosin II, which only performs a single 
stroke with an actin filament during muscle contraction, myoV undergoes pre-stroke and post-
stroke conformational changes, which can be seen in X-ray crystal structures and EM images 
(Coureux et al., 2004; Walker et al., 2000). A first clear picture of how myosin V motor adopts 
different head conformations became available when the Houdusse lab showed the X-ray 
crystal structure of the myosin V motor either in the presence or absence of nucleotides 
(Coureux et al., 2004; Coureux et al., 2003).  
 
The myosin motor head consists of a nucleotide-binding pocket, an actin-binding 
interface, and several deep clefts (Rayment, 1996; Trybus, 2008). The MyoV head domain 
contains an upper 50kDa domain and a lower 50kDa domain that are connected by an internal 
loop, the structure of which forms a cleft. The cleft exists in the middle of the actin-binding 
interface that is contributed by both upper and lower 50kDa domains (Figure 1.3). In the 
absence of nucleotide, a core 7 beta-pleated sheet restructures the conformation of the MyoV 
head in such a way that a cleft assumes a closed position, which brings the actin-binding 
interface together and facilitates a strong binding of the MyoV motor head to actin.  
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The motor head undergoes several stages, “no nucleotide à ATP à ADP + Pi à ADP 
à no nucleotide”, with different affinities toward binding actin. Underlined stages indicate the 
weak actin binding conditions (De La Cruz et al., 1999; Hammer and Sellers, 2012). The 
binding of ATP weakens the actin-myosin interaction. The rate-limiting step in the MyoV 
kinetic cycle is the lease of ADP, which suggests that MyoV has a high duty ratio (i.e., actin 
bound stage) (De La Cruz et al., 1999).  
 
MyoV movement was initially considered to follow either a hand-over-hand or an 
inchworm model. The hand-over-hand model suggests that the trailing head swings after ATP 
hydrolysis, which brings the trailing head forward (74nm) to become a leading head. An 
inchworm model proposes that both heads move by 37nm simultaneously without the 
swinging process. The hand-over-hand model was established when EM images and single 
fluorophore imaging confirmed the model (Walker et al., 2000; Yildiz et al., 2003). Using the 
mouse MyoVa heavy chain and taking a snapshot of MyoVa movement on actin filaments by 
electron microscopy, Walker et al. showed that both heads of myosin V bind to actin filaments 
separated by 13 actin subunits (Walker et al., 2000). By labeling a single calmodulin with their 
optical technique call FIONA [fluorescence imaging with one-nanometer accuracy], Yildiz et al., 
also observed that there was a 74nm fluorophore displacement with MyoV movement (Yildiz 
et al., 2003). Although the leading head was bound to actin in the ADP bound stage, the 
trailing head underwent ATP hydrolysis that generated a power stroke and turned the trailing 
head ahead of the leading head. The new leading head diffused and bound the 13th actin 
subunit in the ADP bound stage and the MyoV kinetic cycle continued (Vale, 2003). 
 
Because MyoV spends most of its kinetic cycle at the actin bound stage, it is considered 
a processive motor protein (De La Cruz et al., 1999). The processivity of yeast Myo2 became 
controversial when Reck-Peterson et al., showed that Myo2 did not co-sediment with actin in 
the presence of ATP, unlike MyoVa from a chick brain (Reck-Peterson et al., 2001). The 
Mooseker lab therefore suggested that at least 5 Myo2 motors are required for the processive 
run on actin cables. In line with this, the Trybus group also claimed that kinesin-related Smy1 
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drove the Myo2 processivity by acting as a passenger (Hodges et al., 2009). In a similar fashion, 
the Trybus group later claimed that Myo2 processivity was also enhanced by tropomyosins on 
actin filaments (Hodges et al., 2012). In the Bretscher lab, Donovan found that about 10 Myo2 
motors were associated with moving secretory vesicles (Donovan and Bretscher, 2012). 
Whether or not a single yeast Myo2 motor in vivo is capable of a processive run on actin cables 
without any activator such as Smy1 remains to be tested. 
 
The lever arm 
The myosin lever arm has IQ motifs – a consensus sequence of IQxxxRGxxxR with a 
stretch of an additional 23-25 amino acid residues in between each IQ motif, where x 
represents any amino acid. A tandem repeat of IQ motifs can be found in heavy chains of many 
myosins. IQ motifs are among the calmodulin and myosin light chain binding targets (Trybus, 
2008). Followed by the longest α-helical lever arm (24nm), the myosin V motor head exerts 
mechanical force that is produced by ATP hydrolysis through the lever arm. The MyoV lever 
arm, which contains six IQ motifs, each of which binds light chains of calmodulin or members 
of the calmodulin family, is three times longer than muscle myosin and eight times longer than 
its motor counterpart, kinesin. The long lever arm allows myosin to take a bigger step for every 
ATP hydrolyzed (37nm) (Vale, 2003). Intramolecular tension between the lever arms due to 
ADP dissociation from the actomyosin-ADP complex generates the power stroke that allows 
the myosin to move in a discrete step of 37nm in a single event (Forgacs et al., 2008). In line 
with this, the Bretscher and Sellers labs also found that lengthening both yeast Myo2 and 
mammalian MyoV to 8IQ also increased the speed of MyoV (Sakamoto et al., 2005; Schott et 
al., 2002).  
 
S. cerevisiae has two IQ motif-binding proteins; calmodulin (Cmd1) and the essential 
myosin light chain (Mlc1) (Stevens and Davis, 1998). Cmd1 was the first of the myosin light 
chain family that was discovered in budding yeast (Cyert, 2001). Both myosin light chains have 
lobe structures at their NH2 and COOH termini. Both N- and C-lobes of Cmd1 bind the IQ1 
motif, which buries an amphiphilic α-helical consensus sequence. Unlike mammalian -  
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calmodulin, CaM, yeast Cmd1 functions in a Ca2+ independent manner, which is shown by the 
cmd1 mutant that fails to bind calcium (Brockerhoff and Davis, 1992). Mlc1 binds IQ2 with 
both of its N- and C-lobes (Figure 1.4). Only the Mlc1 C-lobe binds IQ4 but the N-lobe is still 
open and is proposed to bind other proteins (Terrak et al., 2003). Although IQ motifs are 
highly conserved, variation in a non-consensus sequence is proposed to regulate the myosin 
light chain binding affinity and, subsequently, the MyoV motor function. In mammalian MyoV, 
it has been established that availability of calcium regulates the kinetic cycle of the myosin 
motor (Lu et al., 2006). A low calcium level activates the closed-form of MyoV through CaM 
binding although a high level of calcium stops MyoV motility (Krementsov et al., 2004; Lu et 
al., 2006). The IQ motif in MyoVa can also bind syntaxin-1A (t-SNARE), which displaces CaM 
and supposedly regulates the exocytosis process (Watanabe et al., 2005). 
 
The globular tail domain (coiled-coil and cargo binding domain) 
The tail domain has a coiled-coil motif for homodimerization and the most class-
specific cargo-binding globular tail domain, also known as cargo binding domain (CBD) which 
binds diverse cargos by specific adaptor proteins (Eves et al., 2012; Schott et al., 1999). The 
coiled-coil domain is composed of seven amino acid motifs in tandem or in heptad repeats. The 
hydrophobicity of the 1st and 4th residues facilitates the internal dimerization of the coiled coils 
(Kumar-Singh et al., 1991). The heptad repeats vary from myosin class to class. The longest 
repeat can be seen in muscle myosin II and the shortest repeat, which has virtually no coiled-
coil, in myosin VI. MyoV has an intermediate length of ~ 60 heptad repeats with a PEST site 
after 20 repeats (Trybus, 2008). The PEST site represents an amino acid sequence that is rich 
in Proline (P), Glutamic acid (E), Serine (S), and Threonine (T) and the sequence is found in 
rapidly degraded proteins (Rogers et al., 1986). The site can be cleaved by calpain enzyme in 
vitro (Nascimento et al., 1996). The MyoV motor dimer after PEST site cleavage is referred to 
as MyoV-HMM (heavy meromyosin). The function of PEST site in vivo is not understood clearly. 
Although vertebrate MyoVa, Vb and yeast Myo4 contain PEST sites, vertebrate MyoVc and 
yeast Myo2 do not possess PEST sites in their coiled-coil domains (Reck-Peterson et al., 2000). 
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The coiled-coil domain is also known to interact with Rho3 GTPase, which is also involved in 
exocytosis (Adamo et al., 1999; Robinson et al., 1999).  
 
The cargo-binding domain (CBD) in yeast Myo2 has been crystallized. In vitro 
proteolysis shows that Myo2 CBD has two major subdomains, each of which is composed of 
five α-helices (Pashkova et al., 2006). Subdomain I is primarily responsible for vacuolar 
inheritance, subdomain II for secretory vesicle transport, and each domain is joined by a long 
helix (Figure 1.4) (Catlett and Weisman, 1998; Pashkova et al., 2006). The CBD is involved in 
cargo transport, and by observing the human MyoV, the CBD is also implicated in the inhibited 
state of Myo2 by head to tail interaction (Li et al., 2008). Each cargo has their respective 
receptors or adaptors to bind the CBD. The vacuole receptor-binding site on subdomain I is 
offset by 180˚ from the secretory vesicle binding site on subdomain II. Although each 
subdomain has their respective cargo recognition, both domains are mutually required for 
Myo2 function, which indicates that the globular structure of the Myo2 tail is required for its 
functional conformation. Similarly, mammalian MyoV also has a similar arrangement of 
globular tail domain (Wei et al., 2013). 
 
There have been several findings on phosphorylation regulation of myosin V motor. 
Using mass spectrometry phosphopeptide mapping on MyoV from Xenopus eggs, Karcher et al., 
determined that phosphorylation at the 1650 serine residue in the CBD results in dissociation 
of MyoV from its melanosome organelles. The phosphorylation at site S1650 corresponds to 
calcium/calmodulin-dependent protein kinase II (CaMKII): inhibition of the kinase prevents 
the release of MyoV from its organelle (Karcher et al., 2001). The Bretscher lab also showed 
that residues (1131-1176aa) at the subdomain I were highly phosphorylated and important for 
inhibition of cell growth, as shown by overexpression lethality of the Myo2 CBD alone (1131-
1574aa). The residue T1131 was predicted to be a substrate of cAMP-dependent protein kinase 
A (PKA) (Legesse-Miller et al., 2006). The Weisman lab also found that Ptc1, a type 2C protein 
phosphatase, was necessary for association of Myo2 CBD with its receptors such as Vac17, 
Inp2, and Mmr1 for vacuole, peroxisome and mitochondria transport, respectively. Deletion of 
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Ptc1 resulted in defective vacuole inheritance (Jin et al., 2009). These observations suggest that 
Myo2 association and disassociation with its cargo is also regulated by dephosphorylation and 
phosphorylation events, respectively.  
 
Recently, the Weisman lab has shown that mitochondria and vacuole organelle 
receptors Mmr1 and Vac17 have overlapping binding sites on Myo2 CBD (described later). The 
competition between Mmr1 and Vac17 presumably mediates the volume of each organelle that 
is inherited in daughter cells (Eves et al., 2012). Regulation of the inheritance of diverse 
organelles into the bud by their respective receptors is beginning to emerge. The functional 
importance of class V myosin CBD in polarized growth and organelle segregation has made the 
myosin tail a good candidate to study its specific cargo recognition in detail (Eves et al., 2012; 
Wei et al., 2013).  
 
Myosin V motor : cargo selectivity through receptor availability 
 
With its tail domain, Myo2p transports a variety of cargos to the bud tip: post-Golgi 
secretory vesicles (Govindan et al., 1995; Schott et al., 1999), trans-Golgi network (Arai et 
al., 2008; Rossanese et al., 2001), mitochondria (Altmann et al., 2008; Itoh et al., 2002), 
vacuoles (Catlett and Weisman, 1998; Hill et al., 1996; Ishikawa et al., 2003; Tang et al., 
2003), peroxisomes (Hoepfner et al., 2001), and microtubules (Beach et al., 2000; Hwang et 
al., 2003; Yin et al., 2000). The mammalian homolog MyoV is also involved in cargo transport, 
such as membrane vesicles, mRNA, and melanosomes (Reck-Peterson et al., 2000).  
 
Insight into “The receptor or adaptor model” of Myo2 comes from how the Myo2 cargo-
binding domain (CBD) is able to select diverse cargos with cargo-specific, receptor proteins 
(Hammer and Sellers, 2012; Bretscher, 2003). Structural analysis and genetic mutations of 
Myo2 CBD has allowed mapping of several binding sites for receptor proteins (Eves et al., 2012; 
Wei et al., 2013). Several receptors have been identified; Rab GTPase Sec4 in mediating post-
Golgi secretory vesicles transport (Santiago-Tirado et al., 2011), the Vac17p receptor that 
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interacts with Vac8p on vacuole membrane (Tang et al., 2003; Wang et al., 1998), the Inp2p 
receptor in peroxisomes (Fagarasanu et al., 2006), the Mmr1p in segregating mitochondria 
(Itoh et al., 2004) and the Kar9p-Bim1p in recruiting microtubules (Hwang et al., 2003; Yin et 
al., 2000). I will describe in detail three cargos that are transported by Myo2.   
 
Vacuolar inheritance 
Vacuoles are essential storage organelles involved in cell homeostasis, pH regulation, 
ions storage, and protein degradation (Klionsky et al., 1990). Similar organelles can be found 
in mammals known as lysosomes. Vacuoles are generated by membranes from the secretory 
and endocytic pathways. Vacuolar proteins such as carboxypeptidase Y and proteinase A 
(Klionsky et al., 1990) are sorted at the Golgi complex by Vps proteins (vacuolar protein 
sorting or initially known as vacuolar protein targeting, Vpt) (Banta et al., 1988; Robinson et 
al., 1988).  The idea of vacuolar inheritance began with the observation that vacuoles in the 
bud were connected to their maternal vacuoles by long tubular tracks along actin filaments, 
which suggested that they were segregated actively into the bud (Hill et al., 1996; Weisman 
and Wickner, 1988). Vacuole inheritance is not essential for yeast growth due to the ability of 
cells to synthesize vacuoles “de novo” in the bud. This phenomenon allows scientists to 
classify mutants based on vacuole phenotype rather than overall growth phenotype. Three 
classes of vacuole mutants have been identified (Wang et al., 1996). In Class I, multilobed 
vacuoles were found in vac8, vac9 and vac10 mutants. In Class II, rounded nodules on vacuole 
membranes were found in vac2, vac5, vac6, vac11, and vac12. Enlarged scission defect vacuoles 
were found in Class III vac7 and fab1 mutants.  
 
Receptor-mediated vacuole transport by Myo2 became clear in 1998 when the Weisman 
lab generated the myo2-2 (G1248D) mutant that specifically failed to transport vacuoles into 
the bud (Catlett and Weisman, 1998). They also identified a potential vacuolar receptor Vac8, 
a mutant of which was also defective in vacuole inheritance (Wang et al., 1998). Vac8 is 
myristoylated and palmitoylated at its N-terminus and such modification is important for its 
localization at the vacuolar membrane. Because Vac8 lacks a transmembrane domain (TMD), 
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the interaction between Vac8 and the vacuole is solely due to lipid-membrane interaction. 
However due to lack of direct physical interaction between Myo2 and Vac8, it has been 
suggested that another receptor exists between the Myo2 cargo binding domain and the Vac8 
protein (Wang et al., 1998).  
 
A full picture of vacuolar active transport by Myo2 became clear when Ishikawa et al. 
identified the vacuole receptor Vac17 (Ishikawa et al., 2003). Using the myo2-2 mutant as a 
host that supposedly has a weak interaction between myo2 CBD and Vac8, Weisman and 
colleagues hypothesized that overexpression of the potential bridging receptor will suppress 
myo2-2 mutant. As a suppressor of myo2-2, Vac17 physically interacts with the Myo2 tail and 
deletion of the Myo2 binding site on Vac17 (109-190aa) abrogated vacuole inheritance 
(Ishikawa et al., 2003). Vac17 also interacts with vacuole membrane protein Vac8, and this 
receptor complex Myo2-Vac17-Vac8 is responsible for vacuole inheritance. Vacuole transport is 
regulated by availability of the Vac17 receptor and removal of the PEST sequence on Vac17 
lengthens its stability and vacuoles were aberrantly transported back to the bud neck (Tang et 
al., 2003).   
 
 Vacuole inheritance is also dependent on the cell cycle. Since Vac17 was a critical 
receptor for vacuole transport, the abundance of Vac17 through the cell cycle might predict the 
regulation of vacuole inheritance (Tang et al., 2003). Expression of Vac17 was found to 
fluctuate as the cell growth continued. Vac17 expression peaked during the G1/S phase in 
newly formed buds, and it declined gradually during the M phase in cytokinesis. How Vac17 is 
regulated is interesting. Peng and Weisman claimed that cyclin-dependent kinase (Cdk1) 
controlled Vac17 function by phosphorylation. Phosphorylation of Vac17 was parallel with cell 
cycle dependent movement of the vacuole into the bud. Mutation of the Vac17 phosphorylation 
site resulted in partial defects in vacuole inheritance (Peng and Weisman, 2008). Later, it was 
also found that phosphorylation of Vac17 recruited DmaI and E3 ligase, which were required 
for targeting the Vac17 for proteasomal degradation and for releasing Myo2 from its vacuole 
cargo (Yau et al., 2014).  
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Mitochondrial inheritance 
Mitochondria are required for aerobic respiration and they possess their own set of 
mitochondrial DNA. Unlike vacuoles, mitochondria are branched, tubular networks that spread 
throughout the cell, and their inheritance in the bud is an active process. The first clue that 
mitochondria were transported by actin tracks was found by Drubin and colleagues who 
showed that mitochondrial organization and segregation were defective in actin mutants. In 
wild-type cells, mitochondria were seen as a string-like, tubular structure along actin filaments 
whereas 50% of the mitochondria were seen clumped together in act1-108 and act1-133 
mutants. The mutants had mutations that were critical for myosin binding, which indicated 
that actin-myosin interaction was required for proper organization of mitochondria (Drubin et 
al., 1993).  
 
The first observation that mitochondria displayed ATP-dependent motility on actin 
filaments was made in the Liza Pon lab. Having isolated yeast mitochondria, the Pon lab 
experimented with a modified sliding filament assay on immobilized mitochondria. With a low 
level of ATP (10μM), they observed unidirectional motility of mitochondria, although with a 
higher level of ATP or none at all, mitochondria showed no motility (Simon et al., 1995). This 
finding was consistent with the idea that actin-based Myo2 motors undergo an ATP dependent 
kinetic cycle on actin filaments. However, further experiments on the myo2 mutant showed no 
defect in mitochondrial motility. That was puzzling in the beginning. The year 1995 was full of 
excitement, and many discoveries were made on actin-based Myo2 motor movement. Due to 
limited knowledge of the Myo2 motor at the time, we came to realize why the Pon lab did not 
detect a mitochondrial defect in the myo2 mutant in the first place. A lot of information on the 
Myo2 motor became available in later years. 
 
The myo2 mutant that the Pon lab used was myo2-66, which has a defective secretory 
vesicle transport, rather than mitochondria segregation. The mitochondrial receptors that were 
discovered in later years bind at the Myo2 cargo-binding domain (CBD). The myo2-66 allele, 
however, lies in the motor head domain. This became clear when the Matsui lab identified a 
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receptor for mitochondria inheritance. Using powerful yeast two-hybrid library screening, Itoh 
et al. discovered that the Myo2 tail interacted with the Rab like GTPase Ypt11. The Myo2 tail 
also coimmunoprecipitiated with Ypt11. Overexpression of Ypt11 brought more mitochondria 
into the bud, which suggested that Myo2 was an active transporter for mitochondria by the 
Ypt11 receptor protein (Itoh et al., 2002). However, deletion of ypt11 causes a partial defect in 
mitochondria inheritance, but no effect on mitochondrial motility and morphology (Boldogh et 
al., 2004; Itoh et al., 2002). The Matsui lab further created myo2 mutants: myo2-338 and myo2-
573, which were synthetically lethal with ypt11Δ and defective in mitochondria distribution.  
  
 Another mitochondrial receptor, Mmr1, was discovered when the Matsui lab explored 
overexpression suppression screening on the myo2-573 mutant (Itoh et al., 2004). Although 
deletion of mmr1 or ypt11 had no significant effect on mitochondria distribution, the double 
mutant mmr1Δ ypt11Δ was inviable (Itoh et al., 2004). The Bretscher lab also showed that in 
the absence of ypt11, Mmr1 receptor became essential and was required for active transport of 
mitochondria (Chernyakov et al., 2013). This finding showed that budding yeast has two 
redundant receptors for mitochondria segregation. Eves et al. also identified receptor-binding 
sites on Myo2 CBD. The Ypt11 receptor binds Myo2 subdomain II on CBD, and the binding 
site overlaps with the receptor Sec4 for the secretory vesicle (Eves et al., 2012).  
  
Secretory vesicles 
 Post-Golgi secretory vesicles constitute a major membranous organelle that is 
transported by Myo2 motors in polarized growth (Bretscher, 2003). Composed of a variety of 
proteins, phospholipids, and enzymes, secretory vesicles are targeted towards their 
destinations. Synthesized and originated from the endoplasmic reticulum (ER), several 
proteins in vesicles undergo posttranslational modifications in the Golgi complex, and resume 
their secretory pathway towards the plasma membrane (PM) where they deposit proteins and 
membranes (Barlowe and Miller, 2013). In addition, failure of Myo2p to segregate organelles 
such as the trans-Golgi network, endoplasmic reticulum, vacuoles, mitochondria, and 
peroxisomes to the growing bud is different, phenotypically and fundamentally, from that of 
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Myo2p to deliver secretory vesicles. Myo2 mutants, that fail to transport secretory vesicles, 
cause polarized growth arrest, undergo isotropic growth, and ultimately result in cell death 
(Govindan et al., 1995; Schott et al., 1999). Because my research is on secretory vesicle 
transport, I will describe the secretory pathway briefly below.  
  
Polarized distribution of secretory vesicles  
  
The overall outline of secretion came alive when George Palade first showed the 
sequential steps in the secretory pathway. Pancreatic acinar cells are well known for their 
exocrine function (i.e., secreting digestive enzymes). With the amino acid radiolabeling 
technique, and varying time-pulsed autoradiographs that were coupled with thin-sliced, 
pancreatice cells from guinea pigs, several vesicles were seen to emerge from rough 
endoplasmic reticulum and end at the periphery of zymogen granules at the Golgi complex 
(Jamieson and Palade, 1967a; Jamieson and Palade, 1967b; Jamieson and Palade, 1968). This 
was the first demonstration of the existence of the secretory pathway in the form of small 
vesicles. Palade was awarded the Nobel Prize in 1974.  
 
 Fifteen years later, Peter Novick and Randy Schekman further fine-tuned our 
knowledge of the secretion process in a more defined pathway. Using genetically tractable and 
biochemically testable budding yeast, they created the first ever conditional mutant, sec1-1, that 
accumulated secretory proteins such as invertase and acid phosphatase in small vesicles at the 
restrictive temperature of 37˚C (Novick and Schekman, 1979). Out of 188 mutants that they 
screened, they found 23 complementation groups that could be categorized into early (pre-
Golgi) or late secretory pathways (post-Golgi) (Novick et al., 1981; Novick et al., 1980). Those 
genes became known as building blocks for sequential steps in the secretory pathway and 
Randy Schekman was later awarded the Nobel Prize in 2013.   
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Early secretory pathway 
 A number of secretory proteins such as Sec12, Sec13, Sec18, and Sec23 are involved in 
the early secretory steps (Novick et al., 1981). Blockage in the early steps results in ER 
proliferation and no vesicles will be formed. Synthesis of a small vesicle, or COPII vesicle 
begins at the ER. The COPII vesicle has two layers of coats and is composed of five cytosolic 
proteins: Sar1, Sec23, Sec24, Sec13, and Sec31. In vitro reconstitution of COPII vesicles further 
deepened our understanding of how these proteins worked mechanistically (Barlowe et al., 
1994; Salama et al., 1993).  
 
ER resident protein Sec12 is a GEF for Sar1, thereby activating Sar1 to the GTP-bound 
form. Activated Sar1 reveals its amino amphipathic helix that inserts into the ER membrane. 
Localized Sar1 recruits inner COPII coats comprised of heterodimer Sec23/24 and a small 
curvature is formed at the ER site as a result. Sec23 is a Sar1 RabGTPase-activating protein 
(GAP), and primes the intrinsic GTPase activity of Sar1. With the arrival of the outer coat 
heterotetramer Sec13/31, the hydrolytic activity increases tenfold and COPII vesicle buds off 
from the ER (Fromme and Schekman, 2005). The ordered assembly of vesicle formation is 
highly conserved in other systems, and they are localized at certain ER sites known as ER exit 
site (ERES) in mammalian cells (Jensen and Schekman, 2011).  
 
COPII vesicles represent anterograde movement from ER to Golgi but COPI vesicles 
mediate retrograde movement from Golgi to ER (Spang and Schekman, 1998). The budded 
COPII vesicles diffuse and fuse at the cisternae Golgi with the help of a dozen proteins. The 
first member of the RabGTPases, Ypt1, together with Uso1, a protein that contains an 
extended coiled-coil domain, guides the COPII vesicles (60-70nm) towards the cis-Golgi site 
(Nakajima et al., 1991; Segev et al., 1988). The TRAPPI complex (Transport protein particle I) 
comprised of six subunits (Bet3, Bet5, Trs20, Trs23, Trs31, and Trs33) facilitates the tethering 
of the COPII vesicles at the Golgi membranes by binding of the Bet 3 to COPII Sec23 subunit 
(Cai et al., 2007).   
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Fusion of the COPII vesicle at its target cis-Golgi membrane is completed by the 
SNARE complex (soluble N-ethylmaleimide-sensitive factor attachment protein receptors). 
The SNARE complex has 3 proteins: (1) Synaptobrevin or v-SNARE, (2) Syntaxin or t-SNARE 
and (3) SNAP-25 or t-SNARE (Weber et al., 1998). The complex has a four-helix bundle: one 
helix from the v-SNARE, one from the syntaxin and two from the SNAP-25. Structural analysis 
indicated that a “zero” ionic layer exists in the helix bundle that zippers together, which drives 
fusion of the vesicle with the target membrane. The ionic layer comes from one arginine “R” 
residue on v-SNARE (hence R-SNARE) and three glutatmine “Q” residues from t-SNARE (Q-
SNARE) (Fasshauer et al., 1998; Sutton et al., 1998). With COPII vesicle fusion in budding 
yeast, Bet1 serves as a v-SNARE, but Sed5, Bos1 and Sec22 serve as t-SNAREs (Parlati et al., 
2000). Yeast has at least 24 members of the SNARE family (Burri and Lithgow, 2004). 
However, cells have evolved to function efficiently with compartment-specific SNARE pairs as 
in Golgi, vacuole, and endosomal fusion (Furukawa and Mima, 2014; McNew et al., 2000).  
 
Late secretory pathway parallels the Rab cascade 
 The first insight, that Myo2 motor is essential in late secretory stage and it transports 
secretory vesicles came from the investigation of conditional myo2-66 mutant and actin-
stabilizing mutant tpm1/2 (Johnston et al., 1991; Pruyne et al., 1998). In the Bretscher lab, 
Daniel Schott also observed that mutations in Myo2 CBD, e.g, myo2-12, resulted in a phenotype 
similar to that of the myo2-66 in which vesicles accumulated and resulted in isotropic growth. 
This suggested that Myo2 CBD was a potential target for association of vesicles (Schott et al., 
1999). Another crucial finding by Schott was that reducing the length of the Myo2 lever arm 
(6IQ à 0IQ) significantly decreased the Myo2 mobility from 3μm/s to 0.2μm/s, which was 
coupled with a similar decrease in secretory vesicle movement that was observed by GFP-Sec4 
(Schott et al., 2002). These data suggested that the actin-based Myo2 motor was primarily 
responsible for vectorial transport of secretory vesicles.  
 
 Rab GTPases are master regulators of membrane trafficking (Hutagalung and Novick, 
2011). Ypt31/32 are TGN (Trans-Golgi Network)-localized Rab GTPases. Ypt32 recruits Sec2 
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which is a Sec4 GEF (Ortiz et al., 2002). Sec2 activates cytosolic Sec4 into a GTP-bound form. 
Activated Sec4 is then localized to the exocytic vesicle from the TGN by its  prenyl group at its 
C-terminus (Calero et al., 2003). Both Ypt32 and Sec4 in the GTP state bind the Myo2 tail, 
thereby activating the inhibited form of Myo2 (Donovan and Bretscher, 2012; Jin et al., 2011; 
Lipatova et al., 2008). The crucial importance of the Rab cascade in association with the Myo2 
tail with vesicles was observed clearly in ypt31Δ/ypt32ts when the initial Rab Ypt32 function at 
the TGN was blocked at the restrictive temperature of 37˚C (Lipatova et al., 2008).  
 
 The next puzzle would be establishing the GEF for Ypt31/32. A potential GEF 
candidate was the TRAPPII complex (Morozova et al., 2006). However, controversy abounded 
as several papers presented different findings from different labs. The TRAPPII complex 
consists of 9 subunits: Trs120, Trs130, and Trs65 in addition to the six subunits of TRAPPI 
(Bet3, Bet5, Trs20, Trs23, Trs31, and Trs33). The four subunits of the TRAPPI complex (Bet3, 
Bet5, Trs23 and Trs31) make up a core domain that acts as a Ypt1 GEF, which is involved in 
the ER-Golgi pathway described earlier (Kim et al., 2016). The Segev lab claimed that by 
having three new subunits, the TRAPPII complex exerted its GEF activity on Ypt31/32 at the 
TGN and that facilitated the formation of exocytic vesicle (Morozova et al., 2006). The Susan 
Ferro-Novick group, however, observed that the TRAPPII complex still activated Ypt1 although 
it had no GEF activity on Ypt31/32 pairs. The conflicting finding was further extended when 
Pinar et al. paper showed that the TRAPPII complex activates RabE, Ypt31 ortholog, in 
Aspergillus nidulans (Pinar et al., 2015). It became definitive when the Fromme lab showed that 
TRAPPII complex activates Ypt31/32 and plays an important role in this late secretory step 
(Thomas and Fromme, 2016).  
 
In parallel with the Rab cascade, membrane composition of the Golgi plays a critical 
role. Phospholipid PI4P (phosphatidylinositol 4-phosphate), which is catalyzed by Pik1 (PI 4-
kinase), is enriched in the Golgi membrane (Flanagan et al., 1993; Walch-Solimena and Novick, 
1999). As post-Golgi vesicles mature en route to the plasma membrane, PI4P is converted to 
PI4,5P2 by PM-localized Mss4 (PI4P 5-kinase) (Homma et al., 1998). Therefore changes in the 
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level of PI4P may regulate secretory vesicle transport. Indeed Santiago-Tirado et al., showed 
that increasing the level of PI4P by overexpressing Pik1 suppressed the conditional myo2 
mutant, myo2-12. A chimera with the PH domain that recognizes PI4P fused to Myo2 tail, can 
suppress myo2-12, which suggested that binding PI4P can supplement a defect in the Myo2 
binding Sec4 (Santiago-Tirado et al., 2011).   
 
Exocytic process 
 As post-Golgi vesicles mature in the late secretory stage, activated Sec4 recruits its 
effector Sec15, displacing Ypt31/32 (Medkova et al., 2006; Ortiz et al., 2002). Subsequently 
Sec15, one of the exocyst subunits, primes the vesicle to tether and dock at the PM for fusion 
competence. During the span of 7 years, the Novick lab contributed to a clearer picture of the 
exocyst complex. The majority of the first 23 SEC complementation groups represent the 
exocyst components (Novick et al., 1980). Beginning with Sec8 and Sec15, the Novick lab 
found that vesicles were accumulated in the mutants and that they appeared to be downstream 
of Sec4 (Bowser et al., 1992). Subsequently, with a genetic approach, co-immunoprecipitation, 
and peptide microsequencing, further work by the Novick lab demonstrated that the exocyst is 
a hetero-octomeric complex that contains Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and 
Exo84 (Guo et al., 1999; TerBush et al., 1996; TerBush and Novick, 1995).  
 
The Myo2 tail interacts with Sec15 and Exo70, indicating that the vesicle-transporting 
Myo2 motors dock at the PM by physically interacting with the exocyst (Jin et al., 2011).  
Conditional mutant sec15-1 leads to a polarized accumulation of secretory vesicles in the bud, 
indicating that the exocyst complex plays an important role in vesicles fusion at the plasma 
membrane (Salminen and Novick, 1989; Walch-Solimena et al., 1997). It is still an open 
question whether all 8 subunits of the exocyst complex come together or if they are assembled 
at the site of vesicle fusion in the bud. Using the fluorescence recovery after photobleaching 
method (FRAP), the Novick lab found that six subunits (Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, 
and Exo84p) showed the similar mobility as the secretory vesicle marked by GFP-Sec4 (half-
life = ~ 12s). The other two subunits Sec3 and Exo70 exhibited a slower mode of recovery. 
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Using the actin-depolymerizing agent, Latrunculin A, all six subunits lost their polarity but 
Sec3 and Exo70 retain the polarity in the bud (Boyd et al., 2004). This finding indicated that 
certain subunits of the exocyst complex localized at the plasma membrane and the other 
subunits were recruited as the vesicles matured. Recently the Mary Munson group showed that 
the exocyst complex was comprised of two stable four-subunits modules, which were packed 
together as long rods (Heider et al., 2016). Sec15 and Exo70 occupied the outermost position 
in one module but the other module consisted of Sec3 in its outermost position, which 
suggested that each module had different functions regarding the exocytic mechanism. That is 
Sec15 and Exo70 will react primarily to the cytosolic side of the incoming vesicles and the 
other module facing the PM will cooperate with the PM components. In addition Sec3 directly 
interacted with Rho1 in its GTP-bound form and Sec3 polarity was lost in the rho1-5 mutant 
(Guo et al., 2001). How those Rho GTPases cooperate with the exocyst, vesicle tethering, and 
fusion events at the plasma membrane would be an interesting area of research into the 
secretory pathway.  
 
The secretory vesicle finally reaches its destination, the plasma membrane. The fusion 
of the vesicle membrane and the acceptor membrane (PM) is finally completed by the SNARE 
complex. As described earlier, v- and t-SNAREs help zipper vesicle and acceptor membranes 
together. In the case of vesicle fusion at the PM, Snc1 or Snc2 (v-SNARE) from the vesicle and 
Sso1 or Sso2 (Syntaxin homolog) and Sec9 (SNAP-25 homolog) at the PM pair up to form the 
SNARE complex and fusion occurs (Aalto et al., 1993; Brennwald et al., 1994; Protopopov et 
al., 1993). Regarding the timeline of the events, Bretscher and Donovan showed that Sec4 
RabGTPase, master regulator of vesicle trafficking, needed to be deactivated by its GAP, 
Msb3/4 (Donovan and Bretscher, 2012). The Myo2 motor was then released 4 seconds before 
the final fusion of the vesicle into the membrane (Donovan and Bretscher, 2015).  
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Kinesin motors in brief 
 
 Because kinesin-like Smy1 is the focal point of my dissertation, how Smy1 became a 
scientists’ mystery protein over the last 20 years will be answered by explaining the importance 
of the kinesin motor protein in organelle transport. Discovery of the kinesin motor itself was 
interesting and a rewarding experience for scientists. The first ATP-dependent motor protein 
discovered was skeletal muscle myosin II (Bailey, 1942). While looking for motors in the giant 
axon of squid, Ron Vale and colleagues stumbled upon a novel motor in axons that they named 
kinesin (the Greek kinein meaning, to move) (Vale et al., 1985).  
 
 The founding member of the kinesin superfamily proteins (KIFs) is a heterotetrameric 
motor composed of two identical kinesin heavy chains (KHCs) and two kinesin light chains 
(KLCs) (Gennerich and Vale, 2009). Walking on microtubules in a hand-over-hand manner, 
kinesins in general are plus-end directed motors and dyneins, which is another class of 
microtubule-based motors, are minus-end directed motors. The number of kinesin superfamily 
proteins in mammals has 45 members and 15 families, which have been created based on the 
homology of their domains: Kinesin-1 to Kinesin-14B (Hirokawa et al., 2009; Lawrence et al., 
2004). In neurons, kinesins move distally towards the synapses and transport synaptic vesicle 
precursors. In non-neuronal cells, kinesins are directed from the microtubule organizing center 
to the periphery of the cells. Kinesin motors play several roles in mitochondria, lysosomes, 
endosomes, late-Golgi, and vesicle transport (Hirokawa, 1998; Hirokawa et al., 2009). How 
kinesin motors transport several organelles in molecular detail compared to myosin motors is 
poorly understood. Budding yeast has 6 kinesin motor proteins: Cin8p, Kar3p, Kip1p, Kip2p, 
Kip3p, Smy1p, and one cytoplasmic dynein motor: Dyn1p (aka Dhc1p) (Hildebrandt and Hoyt, 
2000). Of the six kinesins motors, only four motors  (Cin8p, Kip1p, Kip3p, and Kar3p) are 
involved in kinetochore assembly, spindle orientation, chromosome segregation, and mitosis 
(Tytell and Sorger, 2006). 
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 Initially discovered as a suppressor of the conditional myo2 mutant myo2-66, Smy1 
(Suppressor of Myo2) was proposed as a potential candidate for another microtubule-based 
kinesin-related motor protein (Lillie and Brown, 1992). Smy1p has three distinct domains: a 
kinesin-like motor domain, a predicted coiled-coil domain and a C-terminal myosin-binding 
domain (Beningo et al., 2000). Despite the sequence similarity with motor domains of the 
kinesin superfamily, Smy1p does not require microtubules for its function, and deletion of 
SMY1 (smy1Δ) does not affect membrane trafficking and growth overall (Lillie and Brown, 
1998). Characterization of Smy1p function, therefore, suggests an intriguing yet challenging 
investigation. Disruption of microtubules or mutating the potential ATPase residues in the 
Smy1 motor domain does not disrupt Smy1 localization and its suppression activity.  
  
 The first proposal of Smy1 function came to light when the Trybus group claimed that 
Smy1 enhances the processivity of Myo2 by acting as an electrostatic tether to the actin cables 
(Hodges et al., 2009). Although the model is attractive, they did not mention why smy1Δ has 
no overall effect on Myo2 processivity in vivo. Their model showed how Myo2p-ΔGT (lacking a 
globular tail domain) was still processive in vitro due to the abundance of Smy1 that acted as an 
electrostatic tether to the actin cables. However this model fails to explain why overexpressed 
Smy1 can not suppress the temperature-sensitive phenotype of the myo2-14 mutant that was 
created in our lab, which has two mutations at the CBD and amber mutation at 1536aa (stop 
codon) (Schott et al., 1999). Interestingly, the function of Smy1p was revisited in 2011 when 
the Bruce Goode lab showed that Smy1p was a passenger protein on Myo2p and that it acted as 
a formin Bnr1p damper, thereby suppressing the extensive formation of actin filaments that 
originated at the bud neck (Chesarone-Cataldo et al., 2011). Unfortunately, both of these 
models fail to explain why overexpression of Smy1 suppresses the ts phenotype of myo2-66 and 
other conditional myo2 tail mutants (Schott et al., 1999), which left the the exact function of 
Smy1p even more elusive. Therefore my dissertation aims to describe a potential role of Smy1 
in the vesicle transport pathway.  
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Implications of defective Myo2 dependent secretory pathway 
 
Because a vast number of functional proteins are conserved evolutionarily, many of the 
molecules that are involved in membrane trafficking such as the ER and the Golgi apparatus, 
intra-Golgi trafficking, and trans-Golgi to plasma membrane, have their homologs in 
mammalian cells (Schwartz et al., 2007). Intuitively, any disruption in vesicle trafficking 
results in yeast death. Parallel with this phenomenon, interference in mammalian vesicle 
trafficking also causes secretion-related diseases (Ton et al., 2002). The dilute mouse mutant 
has a mutation of the myosin-V, giving rise to a pale coat color and death due to neurological 
disorders three weeks after birth (Mercer et al., 1991), which indicated the importance of 
transport of melanosomes and smooth endoplasmic reticulum (SER) in the skin and neurons, 
respectively (Evans et al., 1997; Takagishi et al., 1996). In humans, MyoVa has been implicated 
in synaptic vesicle transport, myelination, potentiation in the nervous system, and insulin 
secretion (Correia et al., 2008; Prekeris and Terrian, 1997; Sloane and Vartanian, 2007; Varadi 
et al., 2005).  
 
The receptor model of yeast Myo2p in cargo recognition and transport can also be 
applied to mammalian cells. Humans have 38 myosin genes, including three class V myosin 
genes (MyoVa, Vb and Vc) (Berg et al., 2001). MyoVa, the mammalian homolog of yeast 
Myo2p, is involved in pigment transport. Rab27a on melanosomes is recruited by melanophilin 
(Slac2-a adaptor protein) to MyoVa motors for local transport (Fukuda et al., 2002; Sckolnick 
et al., 2013; Strom et al., 2002). A defect in any of the components results in the Griscelli 
syndrome, which is characterized by hypopigmentation and neurodegeneration (Ménasché et 
al., 2002; Pastural et al., 1997). Taking advantages of the similarity of membrane trafficking 
from yeast to humans, some researchers have proposed a new platform to express mammalian 
secretory proteins in yeast ectopically to characterize the proteins involved in 
neurodegenerative diseases (Ocampo and Barrientos, 2011).  
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Focus of the dissertation 
 
With the revolution of so many scientific discoveries and applications over the past half 
century, researchers have turned the 20th century into the molecular biology era. Beginning 
from a crude knowledge of vesicle trafficking in yeast, many labs have made significant 
contributions to understanding the process of vesicle trafficking in molecular detail. Many 
proteins have been identified with respect to their roles in the secretory vesicle pathway. My 
dissertation will highlight molecular functions of the proteins that play important roles in 
regulating vesicle transport.  
 
Smy1 was initially believed to be a microtubule-based kinesin motor protein. Further 
studies showed otherwise. Since then, the function of Smy1 has been claimed to be either a 
Myo2 processivity agent, or an actin filament regulator. The functions of Smy1 seem to have 
many roles and yet those observations do not explain why Smy1 suppresses the myo2-66 
mutant that has a secretory defect. The main function of Smy1 remains elusive. The focus of 
my thesis was to investigate the molecular function of Smy1 suppression on myo2-66 in detail 
which subsequently led to a discovery of a new RhoGAP protein, GYM1 (name given in this 
thesis) that also plays an important role in vesicle trafficking. Because RabGTPases are major 
membrane trafficking proteins, the involvement of Gym1 in the secretory pathway will be the 
first RhoGAP protein that bridges the gap between Rab and RhoGTPases in the yeast secretory 
pathway. The regulatory process imposed by proteins such as kinesin-related Smy1 and 
RhoGAP Gym1 in Myo2 delivery cycle will be applicable to other secretory systems.  
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Chapter II 
 
Kinesin-related Smy1 enhances the Rab-dependent association of myosin-V with 
secretory cargo 
 
Overview 
 
As previously described in Chapter I, the Myo2 motor transports a number of cargos via 
its specific receptors. Initially discovered as a suppressor of the conditional myosin mutant 
myo2-66, Smy1 presents a potential player in the Myo2 dependent cargo transport pathway. 
Due to its sequence similarity to the kinesin motor domain, Smy1 was initially thought to be 
involved in cargo transport. Yeast two-hybrid experiment showed that Smy1 interacts with 
Myo2 cargo-binding domain (Beningo et al., 2000). Smy1p was also found to colocalize with 
Myo2p in the bud by immunofluorescence and also found to colocalize with secretory vesicles 
(Hodges et al., 2009; Lillie and Brown, 1994). Our lab and other groups have shown that 
smy1Δ is synthetically lethal with myo2-66, other conditional myo2 tail mutants, and late 
secretory mutants such as sec2-56, sec4-8 (Lillie and Brown, 1998)[see table II from the paper]. 
All of these findings suggested that Smy1 is most likely to be involved in the Myo2p dependent 
transport of secretory vesicles. In addition, since smy1Δ does not show synthetic genetic effects 
with exocyst complex mutants such as sec5-24, sec15-1, and the SNARE protein, sec9-4, Smy1p 
function is likely restricted to the late secretory vesicle transport rather than in exocytosis 
(Lillie and Brown, 1998; Schott et al., 1999). [Kirk Donovan unpublished data on vesicle 
tracking together with Smy1 also suggests that possibility, i.e., Smy1 have no effect on the 
timeline of vesicle fusion.]  
  
Smy1 function however becomes more diverse as other labs have found different 
phenotypes from smy1 mutant. Trybus group claimed that Smy1 increases Myo2 processivity on 
actin filaments. By acting as an electrostatic tether between Myo2 and actin, Smy1 facilitates 
Myo2 processive run on actin filaments (Hodges et al., 2009). The Goode lab also found that 
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Smy1 is actually a formin damper at the bud-neck. Deleting smy1 causes more kinks in actin 
filaments (Chesarone-Cataldo et al., 2011). With a diverse array of Smy1 function, it was still 
unclear how overexpression of Smy1 can suppress temperature sensitive myo2 mutants that fail 
to transport secretory vesicles. My research on Smy1 therefore tries to elucidate the function of 
Smy1 regarding Myo2 dependent vesicle trafficking. Much of this chapter has been reproduced 
from our publication in Molecular Biology of the Cell (MBoC) (Lwin et al., 2016).  
 
Materials and Methods 
 
Yeast strains and transformation 
Yeast strains and plasmids used in this study are listed in Table 3 and 4. Standard media and 
techniques for yeast growing and transformation were used (Sherman, 1991). Briefly, for 
transformation, 5ml of log phase OD600 = ~ 0.8 cells were harvested and resuspended in a 
mixture of 36μl of 1 M LiAc, 240 μl of 50% PEG 3350 (w/v), 50μl of salmon sperm DNA 
10mg/mL, 1μg of DNA constructs, and volume-adjustable 29 µl H2O (Gietz and Woods, 2002). 
Cells were incubated at 42˚C for 45 minutes and transformants were selected on selective 
synthetic dropout media plates. Gene deletion and chromosomal GFP tagging were performed 
by standard PCR-mediated techniques (Longtine et al., 1998). Plasmids from yeast were 
isolated using the plasmid isolation kit (YeaStar Genomic DNA kit).  
 
Screen for myo2 sensitized alleles (myo2sens) 
The myo2 mutant library cloned into pRS303 (Schott et al., 1999) was used. Briefly, the Myo2 
tail (1119aa – 1574aa) was PCR-mutagenized with forward primer 5’MYO2: ClaI-
GATAATGAAATCGATATTATGGAAGA and reverse primer 3’MYO2: BamHI-
CGGGATCCATTATCATACTATACTATTGACAAATACTTC to make 5 independent DNA 
libraries (Schott et al., 1999). When cut with SpeI and transformed into yeast, the library 
plasmid replaces the EcoRI-ClaI region of MYO2 with the mutagenized sequence. DNA from 
each library was transformed into the smy1Δ+pRS316-SMY1 strain with selection on SD-ura-
his plates at 26˚C. Approximately ~200 colonies/plate with 20 plates were replicated on SD-
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his+5-FOA (5-Fluoroorotic acid) and incubated at 26˚C for 3 days to detect which myo2 
mutant alleles could not grow in the absence of the pRS316-SMY1 plasmid. 33 candidates that 
did not grow on SD-his+5-FOA were chosen and re-confirmed. 17 myo2sens mutants were 
confirmed and sequenced to identify their mutations.  
 
Error-prone PCR of SMY1 and plasmid mutant library construction 
Error-prone PCR was performed as described (Cadwell and Joyce, 1992). The final 
concentration of 0.15mM MnCl2 was used during 10 PCR cycles, giving a mutagenesis rate of 
about 0.67/1000nt. To construct a smy1 mutant library, forward primer 5’SMY1: NotI-
TGAATGTTTGAATAGTAATG located -300 nt upstream of the Smy1 translation start site 
(ATG), and reverse primer 3’SMY1: BamHI-TTTCAATTTTTCTCATTTTTC located 179 nt 
downstream of the Smy1 stop codon, were used to PCR amplify and mutagenize SMY1. An 
upstream fragment (-300 to -600 upstream of the start site) that will create the first crossover 
for homologous recombination was amplified using BamHI-ACATCAAGATTATAGCTGTC and 
XhoI-CAATCACAGTGTATTATCTC primers. This fragment was cloned into pRS304 (TRP1) 
backbone vector after cutting with BamHI and XhoI to generate pRS304-HR. The mutant SMY1 
library was cut with NotI and BamHI and ligated into the pRS304-HR vector to generate 
pRS304-HR-SMY1 library. To collect sufficient mutant library, 10,000 colonies were grown on 
LB+Amp plates and amplified. Before transforming the mutant library into yeast cells, the 
pRS304-HR-SMY1 plasmid was linearized with BamHI.  
 
Screen for conditional smy1 mutants  
Transformation of the strains carrying the myo2-41, myo2-43, myo2-51, and myo2-57 alleles 
(ABY3319, ABY3318, ABY3317, ABY3316) with the pRS304-HR-SMY1 plasmid library with 
selection on SD-his -trp was used to generate new SMY1 alleles. Approximately ~200 
transformants/plate on 15 plates were grown at 26˚C for 3 days. Plates were then replicated on 
another SD-his-trp plate and incubated at 37˚C for 3 days to detect which smy1 mutant alleles 
cannot grow at 37˚C. 21 smy1ts alleles were recovered after retesting, and then sequenced.  
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Plasmid construction 
The integrating plasmids pRS306 GFP-Sec4 (URA3) and pRS306 Myo2cctail-3GFP (URA3) 
used to tag Sec4 and Myo2 have been described (Donovan and Bretscher, 2012). To create 
pRS305 Smy1cctail-3mCherry for chromosomal integration, the C-terminal half of SMY1 
(1000-1968nt) was amplified and ligated into the pRS305 vector between XhoI and BamHI. 
3mCherry was cloned between BamHI and NotI. For homologous recombination, the 3’ region 
of SMY1 between the NotI and SacI sites (427nt) was ligated into the vector. The vector was 
linearized by HindIII before transformation. For 3HA tagging at chromosomal SMY1 gene, the 
3mCherry from pRS305 Smy1cctail-3mCherry was replaced with 3HA. The functional 
construct was verified by western blotting using anti-HA antibody [16B12 (ab130275)]. For 
overexpression constructs, the SMY1 ORF flanked by 1000 nt upstream and downstream was 
cloned into YEp351 between the XmaI and PstI sites. The functional construct was verified by 
western blotting with Smy1 antibody. For creating Myo2-4IQ in BY4741 background, the 
integrating plasmid pRS303 Myo2-4IQ was constructed as described (Schott et al., 2002). To 
create pRS303 myo2-4IQ-41, mutation of I1462T in Myo2 cargo binding region was introduced 
by PCR based site-directed mutagenesis.  
 
Smy1 Antibody generation 
SMY1 tagged with SUMO was expressed in RosettaTM 2(DE3) pLysS competent. Bacterially 
expressed Smy1-SUMO was selected on a Ni2+ resin, and then the SUMO tag cleaved with 
Ulp1. The SUMO-cleaved Smy1p was gel purified and antibodies generated commercially 
(Pocono Rabbit Farm and Laboratory). 
 
Microscopy 
Micrographs were acquired on a CSU-X spinning disc confocal microscopy system (Intelligent 
Imaging Innovations) with a DMI 6000B microscope (Leica), 100x1.45 NA objective and a 
QuantEM EMCCD camera (Photometrics) or an HQII CCD camera (Photometrics) with 2x 
magnifying lens. All images shown are maximum projection of 7 confocal slices taken 0.28 µm 
apart, unless stated otherwise. Images were analyzed and processed with Slidebook 6.0 
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software (Intelligent Imaging Innovations). The images were further adjusted in Photoshop 
(Adobe) to give the clearest presentation of the results and assembled in Illustrator (Adobe). 
For live-cell imaging of yeast cells, cells were attached to a glass-bottomed dish coated with 
Concanavalin A (EY laboratories) and washed with respective cell medium. Imaging at high 
temperatures was performed in an environmental chamber (Okolab). Quantification of the 
number of fluorescent proteins on transporting secretory vesicles was done as described 
(Donovan and Bretscher, 2012). Staining cells with phalloidin has also been described 
(Donovan and Bretscher, 2012).  
 
Yeast two-hybrid constructs and analysis 
The coding sequence for Myo2cctail (2776-4725nt) was fused with the DNA activation domain 
in pGADT7 vector between NdeI and BamHI. The Smy1 myosin-binding domain (1308-1968nt) 
was fused with DNA binding domain in pGBKT7. The AH109 strain co-transformed with both 
plasmids was selected in media lacking leucine and tryptophan (SD-2DO: double dropout). 
Interaction was detected by growth on medium lacking leucine, tryptophan and histidine (SD-
3DO: triple dropout).  
 
Immunoblotting 
Overnight cultures were harvested and resuspended in disruption buffer (20mM Tris-CL, pH 
7.9, 10mM MgCl2, 1mM EDTA, 5% glycerol, 1mM dithiothreitol, 0.3M ammonium sulfate, 
1mM PMSF, and 1x Sigma yeast protease inhibitor cocktail) with 0.1g acid-washed glass beads 
(Sigma-Aldrich, St. Louis, MO, USA). Vigorous vortexing was done at 4˚C for 3 times with 1 
minute each and 1 minute in between resting on ice. The crude lysates were centrifuged at 
17,000 g in a table-top centrifuge in a cold room (4˚C) for 10 minutes and supernatant was 
collected. For temperature sensitive strains, cells were grown at 26˚C overnight, and adjusted 
to log phase OD600=0.8 the next day. Cells were then shifted to 35˚C for 2 hours. Upon 
harvesting, cells were chilled on ice, washed twice with ice-cold water, frozen in dry ice and 
stored at -80°C. The concentrations of protein samples were measured using Bradford assay. 
The samples were resolved by SDS-PAGE, transferred to Immobilon-P membrane (Millipore), 
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then blocked for 1 hour in 5% milk in PBS-T (0.1% Tween). Membranes were incubated with 
primary antibodies for 1 hour: mouse monoclonal anti-GFP antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), or rabbit polyclonal antibody against Myo2tail, Smy1, 
Sec4 (generated in the lab) and G6PDH. After washing, membranes were incubated with 
secondary antibodies: IRDye goat anti-mouse and donkey anti-rabbit antibodies. Membranes 
were analyzed using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE, 
USA).  
 
Coimmunoprecipitation 
Total yeast protein extracts were prepared using the same protocols described above. 10μl of 
GFP-Trap® resin (ChromoTek) was used for 1mg of each cell lysate and agitated at 4˚C for 2 
hours. Bound protein was eluted with 50μl hot (95°C) SDS-PAGE loading buffer. Eluted 
proteins were resolved on 7-15% split SDS gels.  
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Results 
 
Smy1 polarity depends on its association with Myo2.  
 
To explore whether Smy1 polarization is dependent on interaction with Myo2 (Beningo et al., 
2000) or secretory vesicles (Hodges et al., 2009), we examined its localization in specific myo2 
mutants. We have described temperature-sensitive mutations in the tail domain of Myo2 that 
confer defects in transport of secretory vesicles or inheritance of mitochondria (Chernyakov et 
al., 2013; Schott et al., 1999). The conditional mutant, myo2-14, has a 35 amino acid truncation 
of the Myo2 tail that abolishes its two-hybrid interaction with Smy1 (Figure 2.1 A) and confers 
a conditional defect in mitochondrial inheritance (Chernyakov et al., 2013). Consistent with 
the two-hybrid data, SMY1 overexpression has no suppressive effect on the conditional growth 
of myo2-14, but does suppress the conditional growth phenotype of myo2-12 and other tail 
domain mutations that confer a conditional defect in transport of secretory vesicles (Schott et 
al., 1999). In myo2-14 cells both Myo2 and the secretory vesicle marker Sec4 are polarized, yet 
Smy1 is not (Figures 2.1 B and C). Thus, to be polarized, Smy1 requires an interaction with 
Myo2, and is not associated with secretory vesicles independently of Myo2 as suggested 
(Hodges et al., 2009). In order to delineate the function of Smy1, we set out to generate 
mutations in SMY1 that confer a conditional growth phenotype. Analysis of such conditional 
mutants should reveal a function for Smy1. 
 
Isolation of conditional myo2sens smy1ts mutants  
 
Earlier work has shown that cells lacking Smy1 grow well and Myo2 remains polarized (Lillie 
and Brown, 1992). The only reported phenotype of smy1Δ cells is the presence of thicker and 
more kinked actin cables (Chesarone-Cataldo et al., 2011; Eskin et al., 2016). We confirm that 
smy1Δ cells grow well and Myo2 is still polarized (Figure 2.2, A and B). Phalloidin staining of 
actin showed little change in actin structures in smy1∆ cells (Figure 2.2 B). As the effects of 
smy1∆ on actin cables is unrelated to the genetic relationships between -  
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Figure 2.1. Smy1 polarity depends on its association with Myo2.
(A) Yeast two-hybrid interactions between Myo2-cctail (926-1575aa) fused to the activation domain (AD) and Smy1-MBD (Myosin 
Binding Domain; 562-656aa) fused to the binding domain (BD). 
(B) Localization of Myo2, Smy1 and Sec4 in the indicated strains at 26˚C and after shifting to the restrictive temperature at 35˚C for 
1hr; each gene was tagged with three copies of the indicated fluorescent protein. Scale bars, 2μm.
(C) Quantification of small budded cells (≤ 2μm) with polarized Myo2, Sec4 and Smy1 at 26˚C and after shifting to 35˚C for 1hr. 
Error bars indicate SD. (n=50).
Figure 2.1
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Myo2 and Smy1 (Eskin et al., 2016), we have not explored the reason for this apparent 
discrepancy, although it is worth noting that the Eskin et al. study used the W303 genetic 
background, whereas our studies employ the S288C background. 
 
Both the original myo2-66 conditional head domain mutation as well as many of our conditional 
myo2 tail mutations can be suppressed by SMY1 over-expression, indicating a close functional 
relationship between Myo2 and Smy1 (Schott et al., 1999). Moreover, myo2-66 shows synthetic 
lethality with smy1Δ (Lillie and Brown, 1992). Therefore we began our Smy1 journey with 
creating conditional myo2 smy1 mutants so that we can study the molecular function of Smy1 in 
detail. A previous graduate student, Donghao Li, contributed his effort in creating the 
conditional smy1 mutants which I detailed in Materials and Methods. By using the myo2 mutant 
library created by Daniel Schott (Schott et al., 1999), Donghao first created the myo2 mutants 
that were sensitive to smy1Δ, i.e., myo2 smy1Δ is inviable even at the permissive temperature at 
26˚C (Figure 2.2 C and E). 17 such sensitized alleles (myo2sens) were recovered and they have 
between one and four missense mutations (Table 1). Four of these (myo2-41, myo2-47, myo2-51 
each with a single missense mutation and myo2-57 with three) were chosen to further generate 
conditional mutations in chromosomal SMY1 (Figure 2.2 D). We generated 21 myo2 smy1 
mutants. I followed up with sequencing. Sequence analysis showed that these smy1 ts alleles 
contain between one and four mutations (Table 2). Strikingly, almost all the mutations were 
found to lie in the head domain of Smy1 (Figure 2.2 F).  
 
We selected the myo2-41 smy1-15 conditional mutant for detailed study (Figure 2.2 G). The 
myo2-41 mutation alone, or in combination with smy1-15, had no effect on the protein level of 
either Myo2, or its receptor Sec4, when shifted to 35°C for one hour (Figure 2.2 H), or on the 
actin cytoskeleton when cells were grown at 26˚C or shifted to 35˚C (Figure 2.2 I). All the 
strains grew normally at 26˚C and their division times were 90 ± 20 min at 26˚C (n=20 cells 
for each strain). At the restrictive temperature of 35°C, the single myo2-41 and smy1-15 
mutants grew normally with division times of 80 ± 25 min (n=25 cells for each, mean ± SD). 
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Table 1, related to Figure 2.2. Mutations in the myo2sens alleles 
 
myo2sens Mutations 
myo2-41 I1462T  
myo2-42 N1416D      Q1571H  
myo2-43 L1446P  
myo2-44 L1310Q      I1475S  
myo2-45 N1242T     V1448A  
myo2-46 L1446P  
myo2-47 F1347S  
myo2-48 
K1295E      
M1369K      
I1453N      
Y1478F  
myo2-49 L1446P      S1519C  
myo2-50 L1411P      D1431V  
myo2-51 K1444M  
myo2-52 L1446R  
myo2-53 D1186V     N1416Y 
myo2-54 
I1346T      
I1491T      
K1541N  
myo2-55 F1347Y  
myo2-56 L1331F      A1336S 
myo2-57 
W1367R      
Y1415S      
S1520G  
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Table 2, related to Figure 2.3. Mutations in conditional smy1 alleles 
 
smy1ts nucleotide change amino acid change recovered from myo2sens 
smy1-10 T170C L57P myo2-41, myo2-51 
smy1-11 A1588G N529D myo2-41 
smy1-12 T293G A1427G 
I98R 
A476R 
myo2-41, myo2-47, myo2-57 
smy1-13 A515G D172G myo2-41 
smy1-14 T866G I289S myo2-41 
smy1-15 T337C Y113H  myo2-41 
smy1-16 G501A A1087G 
M167I 
R363R 
myo2-41 
smy1-18 T875G L292W myo2-41 
smy1-19 A381G C404T 
S127S 
P135L 
myo2-41 
smy1-20 G85A A352G 
E29K 
S118G 
myo2-41 
smy1-21 T892C S298P myo2-41 
smy1-22 A700G R234G myo2-41 
smy1-23 
 
T190C 
T434C  
L64L  
L145P 
myo2-41, myo2-47 
smy1-24 
T76C 
G176A 
T1217C  
C26R 
R59H 
I406T 
myo2-41, myo2-57 
smy1-25 T805C F269L myo2-41 
smy1-26 
A1062G 
C1161T 
T1498C 
C1761T  
T354T 
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myo2-41 smy1-15 mutant confers a conditional defect in binding secretory vesicles 
 
The sensitizing mutation in myo2-41 (I1462T) lies on the surface of the Myo2 tail adjacent to 
the Rab binding site to which Sec4, Ypt31/32, and Ypt11 bind (Figure 2.3 A) (Eves et al., 
2012). The mutation in smy1-15 (Y113H) lies in the kinesin-like motor domain (Figure 2.3 B). 
To explore the localization of Myo2 and Smy1 in these cells, each was tagged with different 
fluorescent proteins, which did not affect the growth characteristics of the strains. The Myo2 
motors are polarized to the site of growth in MYO2, myo2-41, and smy1-15 cells at both 26˚C 
and after shifting to 35˚C (Figure 2.3, C and E). When the double mutant myo2-41 smy1-15 was 
shifted to the restrictive temperature for one hour, the polarization of myo2-41-3GFP persisted 
whereas smy1-15-3mCherry became depolarized. This depolarization of Smy1-3mCherry was 
also seen after a short shift to the restrictive temperature (Figure 2.3 C). We next sought to 
determine the effect of the mutations on secretory vesicle delivery. Secretory vesicles marked 
with chromosomally tagged GFP-Sec4 were polarized in the single mutants, but in the double 
myo2-41 smy1-15 mutant they were depolarized after a short shift to 35˚C (Figure 2.3, D and E). 
Thus, the conditional smy1-15 mutation results in both a dissociation of Smy1 from Myo2 and a 
defect in secretory vesicle transport at the restrictive temperature. 
 
To determine whether the different myo2sens alleles might have yielded smy1 alleles potentially 
affecting different functions, we combined myo2-41 with 15 of the smy1 alleles we had 
generated in different myo2sens backgrounds. All 15 grew at the permissive temperature, and 
became inviable at the restrictive temperature (Figure 2.3 F), suggesting that all the smy1 
alleles are affecting the same function. To document this further, we also characterized the 
single and double mutants of myo2-57 smy1-12 and found that the same uncoupling of both 
secretory vesicles and Smy1 from polarized Myo2 occurred at the restrictive temperature. Thus, 
the combined genetic and localization data reveal that a critical function of Smy1 in the myo2sens 
strains is to link Myo2 to secretory vesicles. 
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Figure 2.3 (continued). myo2-41 smy1-15 mutant confers a conditional defect in binding secretory vesicles.
(D) Localization of Sec4 in the indicated strains at 26°C or after shifting to 35°C for 1hr or 10 min for myo2-41 smy1-15. Scale bars, 
2μm.
(E) Quantification of small budded (≤ 2μm) cells with polarized Myo2, Sec4 and Smy1 at 26˚C and after shifting to 35˚C for 1hr. 
Mean values are from three independent experiments (n=50 each) and error bars indicate SD. 
(F) Growth assay of myo2-41 coupled with several smy1ts alleles. 10 fold serially diluted cells spotted on YPD plates at 26˚C and 
35˚C and incubated for 2 days. 
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The myo2-41 allele compromises the ability of Myo2 to bind Sec4. 
 
The sensitizing mutation in myo2-41 lies adjacent to the Rab binding site (Figure 2.3 A). Yeast 
two-hybrid analysis showed that myo2-41 is compromised in its ability to interact with Sec4 
(Figure 2.4 A), thereby implying that Smy1 likely functions to enhance the interaction between 
Myo2 and Sec4 necessary for secretory vesicle transport. Consistent with this model, 
overexpression of SEC4 from a multi-copy plasmid suppresses the myo2-41 smy1-15 mutant and 
results in repolarization of GFP-Sec4 (Figure 2.4, B, C and D). Indeed, overexpression of SEC4 
suppresses all the myo2-41 smy1ts mutants (Figure 2.4 E). However, over-expression of SEC4 
was unable to suppress the lethality of myo2-41 smy1∆ (Figure 2.4 F). Therefore, even when 
SEC4 is over-expressed, Smy1-15 still provides an essential function in myo2-41 smy1-15 cells at 
the permissive temperature.  
 
Smy1 enhances the association between Sec4 and Myo2 and their association with 
secretory vesicles 
 
The interaction between Sec4 and Myo2 is difficult to capture by coimmunoprecipitation, 
presumably because it is relatively transient and only exists during transport and tethering of 
secretory vesicles. Thus, in immunoprecipitates of Myo2-3GFP, only a trace of endogenous 
Sec4 can be detected (Figure 2.5 A). Since Smy1 and Sec4 bind Myo2 (Beningo et al., 2000; 
Santiago-Tirado et al., 2011), SMY1 over-expression might enhance the Myo2/Sec4 interaction. 
Consistent with this model, when SMY1 is overexpressed in an otherwise wild type cell, a 
significant amount of endogenous Sec4 is recovered in Myo2-3GFP immunoprecipitates 
(Figure 2.5 A), without affecting the levels of endogenous Myo2 or Sec4 (Figure 2.5, B and C). 
Moreover, Smy1 is also recovered with Myo2 and Sec4. 
 
To explore whether Smy1 expression affects the number of Myo2 motors or Sec4 receptors 
associated with secretory vesicles, we quantitated the number of each in SMY1, smy1∆ and 
SMY1 overexpressing cells. 
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To quantify the number of Myo2 molecules, we used as standard the 80 Cse4-3xGFP 
centromeric histone molecules per anaphase cluster (Lawrimore et al., 2011). As the speed of 
transport of actively transporting secretory vesicles is very fast in wild type cells and precludes 
estimating the numbers of these molecules on vesicles, we have previously quantitated the 
number of molecules on the slower moving secretory vesicles in cells where the Myo2 protein 
has been altered to have 4IQ motifs rather than the normal 6IQ motifs, which has no effect on 
growth rate (Schott et al., 2002). In these Myo2-4IQ cells, secretory vesicles being actively 
transported utilize about 40% of the total Myo2 in the cell with each vesicle having about 10 
Myo2 motors (Donovan and Bretscher, 2012). Using the same strategy, we confirm that there 
are about 11 ± 4 (n=52) Myo2 motors on moving secretory vesicles in Myo2-4IQ cells, and 
this is not significantly altered in smy1∆ cells, 11 ± 5 (n=45) (Figure 2.5, D and E). However, 
in cells overexpressing SMY1, where the Smy1 level is enhanced about 20-fold due its presence 
on a 2µ plasmid, the number of motors per transporting secretory vesicle is increased about 1.5 
fold, to 15 ± 4 (n=60), representing about 60% of all the motors in the cell (Figure 2.5 E). 
Also consistent with earlier results, we found that there are 50 ± 14 (n=50) and 47 ± 13 
(n=50) Sec4 molecules per secretory vesicle in wild-type and smy1Δ cells, respectively. 
Overexpression of SMY1 also enhances the number of GFP-Sec4 receptors per transporting 
secretory vesicle by about 1.5 fold to 75 ± 15 (n=50) (Figure 2.5, F and G). Thus, SMY1 
overexpression significantly enhances the number of Myo2 and Sec4 copies per secretory 
vesicle.  
 
We also estimated the number of Smy1 molecules per secretory vesicle. Since Smy1 has a 
potential coiled-coil region between its head and tail, we first explored whether it has the 
ability to dimerize in vivo. Plasmids driving the expression of either Smy1-3GFP (Smy1-FL) or 
just the head (Smy1-KLD-3GFP, 1-382aa), or the head and coiled-coil region of Smy1 (Smy1-
KLD+CC-3GFP, 1-562aa) were introduced into a strain expressing Smy1-3HA from its 
endogenous promoter. Smy1-3HA was immunoprecipitated, and both Smy1-3GFP and Smy1-
KLD+CC-3GFP, but not Smy1-KLD-3GFP, were found to coimmunoprecipitate with it (Figure 
2.5 H).  
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Figure 2.5 (continued). The association between Myo2 and Sec4, and with secretory vesicles, is enhanced by full length Smy1. 
(F) and (G) Number of GFP-Sec4 per moving secretory vesicle respectively. Data from puncta captured in three consecutive time-lapse 
frames were analyzed. n = 50. Three asterisks indicates P value <0.0001.
(H) Coimmunoprecipitation of full length Smy1 tagged with 3HA from different Smy1 constructs with or without coiled-coil domain 
tagged with 3GFP. 
(I) Smy1-3GFP puncta (arrows) on moving vesicle in wild-type. 
(J) Quantification of number of Smy1 homodimers per moving secretory vesicle. Data from puncta captured in three consecutive 
time-lapse frames were analyzed. n = 50.
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Thus, Smy1 can oligomerize through its CC domain, most likely existing as a homodimer in 
vivo. Quantitating the fluorescence in cells expressing Smy1-3GFP revealed that about 22 
Smy1 homodimers (22 ± 6 (n=46)) are estimated to be present on each transporting secretory 
vesicle (Figure 2.5, I and J). Given the possibility of a systematic difference in the fluorescence 
of GFP tagged to different proteins, the best we can conclude is that Smy1 and Myo2 are both 
in the range of 10-20 molecules per secretory vesicle, but the possibility on an excess of Smy1 
over Myo2 remains an open question. 
 
We also wished to estimate the number of Sec4 and Myo2 molecules in our conditional myo2-
41 smy1-15 mutant. We therefore tagged endogenous SEC4 with GFP, and the amount of GFP-
Sec4 per moving secretory vesicle in the single and double mutants at both 25° and after a 5 
minute shift to the restrictive temperature. None of the single or double mutants at either 
temperature had a significantly different number of copies of GFP-Sec4. (Figure 2.6 A). As 
explained above, to count the number of Myo2 motors, we needed to reduce the number of IQ 
repeats in the myo2-41 allele from the wild type 6IQ to 4IQ, to generate myo2-4IQ-41. 
Surprisingly, when we did this, the temperature sensitivity of myo2-14 smy1-15 was eliminated, 
whether or not the myo2-4IQ-41 was tagged or not (Figure 2.6 B).  This allowed us to estimate 
the number of Myo2 dimers in the single and double mutants at the two temperatures.  
Consistent with robust growth, the number of Myo2 dimers was not significantly changed in 
these mutants (Figure 2.6 C).  These unexpected results may provide additional insights into 
the function of Smy1, which we offer in the Discussion. 
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Figure 2.6. Number of Sec4 and Myo2-4IQ-3GFP motors per secretory vesicle in myo2 smy1 mutant.  
(A) Number of GFP-Sec4 per secretory vesicle in different strains at both 26˚C and after shifting to 35˚C for 5 min. Error bars 
indicate SD. 
(B) Growth assay of the indicated strains in which Myo2 has either 6IQ or 4IQ motifs. 
(C) Number of Myo2-4IQ-3GFP motors per secretory vesicle in different strains at both 26˚C and after shifting to 35˚C for 15 min. 
Error bars indicate SD.
Figure 2.6 
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The tail domain of Smy1 is critical for its polarization, and the coiled-coil and head 
domains are essential for its function.  
 
To dissect the contribution of the different domains in Smy1, we expressed several Smy1 
constructs tagged with GFP behind the endogenous promoter in smy1Δ cells (Figure 2.7 A). Of 
these, only full length and a construct containing the coiled-coil and myosin-binding domain 
(Smy1-CC-MBD-3GFP) were polarized in otherwise wild type strains (Figure 2.7 B). Further, 
whereas SMY1 overexpression can suppress the temperature-sensitivity of myo2-12, -13, -16 and 
-66 (Schott et al., 1999), constructs overexpressing either a SMY1 construct lacking the Myo2-
binding domain (KLD+CC) or lacking the head domain (CC-MBD) cannot (Figure 2.7 C). 
Therefore, the Smy1 coiled-coil and myosin-binding domains are necessary for localization, and 
the full-length protein is required for its function. Consistent with this, overexpression of full-
length SMY1 enhanced the association of Sec4 with immunoprecipitated Myo2-3GFP, whereas 
over-expression of Smy1 lacking the head domain does not and was not recovered in the 
immunoprecipitates (Figure 2.7 D). Thus, the head domain of Smy1 is critical for its function 
enhancing the association between Myo2 and Sec4. In support of this conclusion, 
overexpression of either full-length smy1-12 or smy-15, that carry missense point mutations in 
the head domain, were unable to suppress any of these conditional myo2 alleles (Figure 2.7 C).  
 
Smy1 function with Myo2 is restricted to the transport of secretory vesicles 
 
Myo2 is involved in the segregation of essentially all organelles during the cell cycle (Bretscher, 
2003). One of these, mitochondria, also involves an interaction with a Rab protein Ypt11 (Itoh 
et al., 2002). Active segregation of mitochondria requires an association of Myo2 with either 
Mmr1 or Ypt11, and in the absence of this segregation, yeast is inviable (Chernyakov et al., 
2013; Itoh et al., 2004). Mutations that reduce Ypt11 binding to the Rab-binding site of the 
Myo2 tail render MMR1 essential (Chernyakov et al., 2013). 
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Figure 2.8. Smy1 function with Myo2 is restricted to the transport of secretory vesicles. 
(A) Wildtype and myo2-41 smy1-15 cells expressing GFP-Sec4 and the mitochondrial marker Mito-RFP after shifting to 35° for 1hr. 
Scale bars: 2μm.
(B) Percentage of cells with mitochondria in the buds at 26° or after shifting cells to 35° for 1hr. Mean values from three independent 
experiments (n=50) and error bars indicate SD. 
(C) Affect of mmr1Δ on the growth of myo2-41 and myo2-57 for 2 days at 26˚C and 35˚C. 
(D) Growth of cells overexpressing SEC4 or SMY1 in wild type and mmr1∆ cells.  
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We examined whether myo2-41 smy1-15 might have a defect in mitochondrial distribution. 
Whereas GFP-Sec4 polarization is strongly affected in myo2-41 smy1-15 cells at 35°C, there is no 
significant defect in mitochondrial inheritance, suggesting that Smy1 function may be specific 
to coupling secretory vesicles with Myo2 motors (Figure 2.8, A and B). Further, the myo2-41 
and myo2-57 mutations that renders SMY1 essential, have no growth defect at any temperature 
when combined with mmr1∆, which makes mitochondrial inheritance dependent on the Myo2-
Ypt11 interaction (Figure 2.8 C). 
 
To explore in a different manner whether Smy1 can enhance the association of Rab proteins 
other than Sec4 with Myo2, we looked in more detail at mitochondrial inheritance. In mmr1∆ 
cells, mitochondrial inheritance is dependent on Ypt11, whose binding site overlaps with Sec4 
on domain II of Myo2 (Eves et al., 2012). If Smy1 enhances the binding of all Rab proteins to 
the Myo2 tail, its over-expression might enhance mitochondrial inheritance. However, if it is 
specific for Sec4, SMY1 overexpression might compromise the availability of the Myo2 tail to 
bind Ypt11. To test this idea, we initially examined whether Sec4 overexpression compromised 
mitochondrial inheritance in MMR1 and mmr1∆ cells. Although the cells remain viable (Figure 
2.8 D), there is a clear defect in mitochondrial inheritance in mmr1∆ cells with most of the 
mitochondria being retained in the mother cell (Figure 2.8, E, F and G). Similarly, when SMY1 
is overexpressed in mmr1∆ cells, there is a defect in mitochondrial inheritance (Figure 2.8, E, F 
and G), showing that Smy1 functions with Sec4 and not with Ypt11. This effect is only seen 
when full-length SMY1 is overexpressed, as no defect is seen when Smy1-CC-MBD is 
overexpressed, further indicating that the Smy1 head domain is necessary for its function 
(Figure 2.8H).  Thus our data imply that Smy1's role is specific to secretory vesicles.  
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Discussion 
 
The mechanism by which molecular motors are activated and bind and transport specific 
cargos is critical for understanding the functional organization of cells. The myosin-V class of 
motors is found in all fungi and animal cells, as well as plants where they are called myosin-X1 
motors (Hammer and Sellers, 2012). Myosin-Vs are well known to bind Rab proteins - 
mammalian myosin-Vs have been shown to bind Rabs 8, 10 and 11 directly, and Rab27a 
indirectly through melanophilin (Hammer and Sellers, 2012). In yeast, Myo2 binds four of the 
11 Rab proteins: Ypt31/32 (Lipatova et al., 2008), Sec4 (Jin et al., 2011; Santiago-Tirado et al., 
2011) and Ypt11 (Chernyakov et al., 2013; Eves et al., 2012; Itoh et al., 2002). 
 
Since its identification more than 20 years ago as an over-expression suppressor of the 
conditional myo2-66 mutation, the specific function of Smy1 has been mysterious. The early 
genetic data discussed in the introduction made a strong case that it functions with Myo2 and 
is involved in some aspect of the late secretory pathway. Here we have generated myo2sens 
mutations that confer no obvious phenotype except to render SMY1 essential, thereby allowing 
for the subsequent isolation of conditional mutations in SMY1. Analysis of the phenotype of 
myo2sens smy1 conditional mutants reveals a clear defect in the transport of post-Golgi secretory 
vesicles, very similar to the phenotype of conditional myo2 mutations that affect this function. 
This is a clear indication that Smy1's function is to cooperate with Myo2 in secretory vesicle 
transport. Additional support for this conclusion - and the specificity of this function - is 
discussed below. 
 
The reported two-hybrid interaction between the tail of Myo2 and the tail of Smy1 was not 
readily reproduced in vitro or by co-immunoprecipitation, so naturally the validity of the two-
hybrid interaction was questioned (Beningo et al., 2000; Hodges et al., 2009). Here we show 
that the polarized colocalization of Smy1 with Myo2 is lost when either a myo2 mutant 
defective in binding Smy1 is examined, or when Smy1 lacking the Myo2 binding domain (MBD) 
is expressed. Further, the region of Smy1 necessary for the two-hybrid interaction is also 
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necessary for its ability to suppress conditional myo2 mutations. In cells where Smy1 is over-
expressed, Smy1 is recovered in immunoprecipitates of endogenous Myo2. These results make 
a compelling case for the relevance of the original Myo2-Smy1 two-hybrid interaction (Lillie 
and Brown, 1998). 
 
We have also delineated functions for the other two domains of Smy1, the coiled-coil region 
and the kinesin-related motor domain. The coiled-coil region is required, with the Myo2-
binding region, for the polarized distribution of Smy1. This is almost certainly because the 
coiled-coil region is necessary for the dimerization, or oligomerization, of the protein. One 
intriguing possibility is that the binding of just one Myo2-binding region to Myo2 is not of 
sufficient affinity to localize the protein, whereas the combination of two low affinity sites may 
be sufficient. The head domain is not polarized on its own, or in constructs together with the 
coiled-coil domain, thus revealing that the Myo2-binding region is necessary for Smy1's 
polarized distribution. Although just the a construct lacking the head domain of Smy1 is 
polarized, the full-length protein (KLD-CC-MBD) is necessary to suppress the conditional myo2 
mutations, and to provide the essential function in our newly generated myo2sens alleles. 
Therefore the kinesin-like head is a functionally important domain of Smy1.  
  
What is the precise function of Smy1? In otherwise wild-type cells, we have found that SMY1 
over-expression enhances the association of Sec4 with Myo2 as assessed by 
coimmunoprecipitation, and also enhances the number of Sec4 receptors and Myo2 motors on 
secretory vesicles. One simple possibility that we favor and is consistent with our data is that 
Myo2/Sec4-GTP/Smy1 form a ternary complex in which Smy1 enhances the association 
between Myo2 and Sec4. The finding that there are sufficient Smy1 molecules, and an excess of 
Sec4 receptors, to engage all the Myo2 motors on transporting secretory vesicles is consistent 
with this model.  So far, our attempts to reconstitute a Myo2/ Sec4 /Smy1 complex on lipid 
vesicles has not been successful - the conditions may not be correct, such as a specific lipid or 
curvature requirement, or another protein might be required.  If another factor functions with 
Smy1 in this process, and this function is essential, deletion of the gene for the factor should 
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be synthetically lethal with smy1∆. We therefore explored the literature and data bases for 
genetic interactions that may support this possibility. As mentioned above, smy1∆ is 
synthetically lethal with myo2-66, sec4-8 and sec2-41 (Lillie and Brown, 1998). The SGD data 
base reports that smy1∆ is synthetically lethal with bem1∆, bem2∆, bni1∆, and cla4∆, each of 
which affects the integrity of actin cables, the substrate on which Myo2 transports secretory 
vesicles. No obvious candidates functioning with Smy1 are found among the other reported 
genetic or biochemical interactions.  Thus, we believe that Smy1 functions to make the 
interaction between Myo2 and Sec4 more robust, perhaps using a coincidence detection 
mechanism to enhance specificity.  
 
We were initially surprised to find that shortening of the myo2-41 neck domain from 6IQ 
motifs to 4IQ fully suppressed the temperature sensitive growth phenotype of the myo2-41 
smy1-15 mutant. However, this result further clarifies the role for the cooperation between 
Smy1 and Sec4 in binding Myo2.  We have shown that Myo2 is activated by binding to 
secretory cargo (Donovan and Bretscher, 2012). We have also shown that wild type Myo2 
undergoes a head-to-tail interaction that regulates the activity of Myo2.  Moreover, the MYO2-
4IQ allele, while not affecting the overall growth rate, partially activates the motors resulting in 
a higher percentage of active motors (Donovan and Bretscher, 2015). The finding that partial 
activation of Myo2 can overcome the temperature sensitivity, suggests that the problem in the 
myo2-14 smy1-15 strain is in motor activation of Myo2.  The myo2-41 mutation reduces the 
affinity for Sec4, which presumably impairs Sec4's ability to activate Myo2 and therefore makes 
Myo2 activation dependent on Smy1. This strongly suggests that Smy1 cooperates with Sec4 in 
the activation step of Myo2 for transport of secretory vesicles.  Remarkably, in the Myo2-4IQ 
background, the number of motors on secretory vesicles is independent of the myo2-41 or smy1-
15 mutations, possibly suggesting that the cell has a robust mechanism to regulate motor 
number on secretory vesicles. 
 
What is the biological function of Smy1's kinesin-like head domain? Essentially all the 
mutations we generated to make the conditional smy1 alleles were found to lie in the head, 
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underscoring the importance of this region for the function of Smy1. This is surprising, as one 
would expect the mutations to lie in the Myo2-binding region.  However, it is possible that 
mutations in the Myo2-binding region are too severe to generate a conditional phenotype, 
whereas subtle perturbations in the Smy1 head may be more easily tolerated. In support of this, 
there are no obvious mutational hotspots in the head, suggesting that a variety of small 
perturbations may be able to generate a conditional phenotype. Whatever the reason, it 
emphasizes that the head is functionally important. One possible function it might have is to 
bind Sec4, but we have not been able to detect a two-hybrid interaction between Sec4 and 
Smy1's head domain. Another possibility is that Smy1's head binds to another component 
present on secretory vesicles, thereby enhancing the association of Myo2 with them, and 
possibly indirectly enhancing the number of Sec4 receptor molecules.  
  
The cooperation between Sec4 and Smy1 in the Myo2-dependent transport of secretory vesicles 
is reminiscent of the involvement of the mitochondrial receptors Mmr1 and the Rab Ypt11 in 
the segregation of mitochondria, another essential function of Myo2 (Chernyakov et al., 2013). 
This similarity is underscored by the finding that Sec4 and Ypt11 bind to the same Rab-binding 
site on the Myo2 tail (Eves et al., 2012), and that over-expression of Sec4 negatively impacts 
mitochondrial inheritance in an mmr1∆ strain.  Moreover, in both cases the receptors Mmr1 
and Ypt11, and Sec4 and Smy1, bind directly to Myo2. A significant difference is that Mmr1 or 
Ypt11 can each provide the essential bridge to Myo2 for mitochondrial inheritance, whereas 
Smy1 cannot provide the essential secretory vesicle function as loss of Sec4 cannot be bypassed 
by Smy1 over-expression. This may be because Sec4 has the additional essential function of 
binding the exocyst for vesicle tethering.  So far there are no sec4 separation of function alleles 
that affect just transport and not tethering, which could be used to address whether Smy1 
alone is sufficient for coupling Myo2 to secretory vesicles. 
 
Our genetic data strongly imply that Smy1's role is specific to secretory vesicles. First, over-
expression of Smy1, where the association between Sec4 and Myo2 is enhanced, compromises 
the Ypt11-Myo2 interaction necessary for mitochondrial inheritance in mmr1∆ cells. Moreover, 
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our myo2sens mutations that render SMY1 essential and compromise the interaction of Sec4 with 
the Myo2 tail, have no effect on mitochondrial inheritance even in an mmr1∆ background. 
 
In summary, we have found that an important function of Smy1 is to cooperate with Myo2 and 
Sec4 in the transport of secretory vesicles for polarized growth. It is not clear why a kinesin-
related protein should perform this function.  It is possible that it derives from an evolutionary 
relic reflecting a time when secretory vesicles were first transported by a kinesin on 
microtubules and then by a myosin-V on actin filaments, making their association and 
functional interplay meaningful. The report of a direct interaction between mammalian kinesin 
and myosin-Va (Huang et al., 1999) supports such a possibility. 
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Table 3, Yeast strains used in this study 
Strain Genotype Parent 
BY4741 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  
BY4742 MATαlpha his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0  
ABY4035 smy1∆::KanR his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 BY4741 
ABY3313 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR BY4741 
ABY4007 MYO2-3GFP::URA3 trp1∆::KanR ABY3313 
ABY4009 MYO2-3GFP::URA3 smy1∆::KanR ABY4035 
ABY4143 GFP-Sec4::URA3 trp1∆::KanR ABY3313 
ABY4144 GFP-Sec4::URA3 smy1∆::KanR ABY4035 
ABY2408 MATa MYO2-4IQ::HIS3  
ABY3189 MATa MYO2-4IQ-3GFP::URA3 pRS415-RFP-Snc2 ABY2408 
ABY3122 MATα CSE4-3GFP::TRP1 YWL980 
ABY4129 MATa his3Δ1 leu2Δ0 ura3Δ0 trp1∆::KanR SMY1-3GFP::URA3 ABY3313 
ABY3315 MATa myo2-47::HIS3 leu2Δ0 ura3Δ0 met15Δ0 trp1Δ::KanR BY4741 
ABY3316 MATa myo2-57::HIS3 leu2Δ0 ura3Δ0 met15Δ0 trp1Δ::KanR BY4741 
ABY3317 MATa myo2-51::HIS3 leu2Δ0 ura3Δ0 met15Δ0 trp1Δ::KanR BY4741 
ABY3318 MATa myo2-43::HIS3 leu2Δ0 ura3Δ0 met15Δ0 trp1Δ::KanR BY4741 
ABY3319 MATa myo2-41::HIS3 leu2Δ0 ura3Δ0 met15Δ0 trp1Δ::KanR BY4741 
ABY4151 MATa myo2-41-3GFP::URA3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  ABY3319 
ABY3320 MATa myo2-41::HIS3 smy1-15::TRP1 trp1Δ::KanR ABY3319 
ABY4171 MATa myo2-41-3GFP::URA3 smy1-15-3mCherry::LEU2 ABY3320 
ABY4158 MATa myo2-41::HIS3 GFP-Sec4::URA3 ABY3319 
ABY4182 MATa smy1-15::TRP1 his3Δ1 leu2Δ0 ura3Δ0 trp1Δ::KanR ABY4741 
ABY4181 MATa smy1-12::TRP1 his3Δ1 leu2Δ0 ura3Δ0 trp1Δ::KanR ABY4741 
ABY4167 MATa MYO2-3GFP::URA3 smy1-15::TRP1  ABY4182 
ABY4010 MATa MYO2-3GFP::URA3 smy1-12::TRP1  ABY4181 
ABY4152 MATa myo2-57-3GFP::URA3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  ABY3316 
ABY3351 MATa myo2-57::HIS3 smy1-12::TRP1 trp1Δ::KanR ABY3316 
ABY4179 MATa myo2-57-3GFP::URA3 smy1-12-3mCherry::LEU2 ABY3351 
ABY4098 MATa myo2-57::HIS3 GFP-Sec4::URA3 ABY3316 
ABY4048 smy1∆::KanR pRS316-SMY1-3GFP ABY4035 
ABY4049 smy1∆::KanR pRS316-SMY1-KLD-3GFP ABY4035 
ABY4050 smy1∆::KanR pRS316-SMY1-CC-3GFP ABY4035 
ABY4051 smy1∆::KanR pRS316-SMY1-MBD-3GFP ABY4035 
ABY4052 smy1∆::KanR pRS316-SMY1-KLD+CC-3GFP ABY4035 
ABY4053 smy1∆::KanR pRS316-SMY1-CC+MBD-3GFP ABY4035 
ABY4054 smy1∆::KanR pRS316-SMY1-KLD+MBD-3GFP ABY4035 
ABY2766 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆ AH109a 
ABY3319 MATa myo2-41::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR ABY3313 
ABY3318 MATa myo2-43::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR ABY3313 
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ABY3317 MATa myo2-51::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR ABY3313 
ABY3316 MATa myo2-57::HIS3 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR ABY3313 
ABY4300 MATa MYO2-4IQ::HIS3 BY4741 
ABY4313 MATa MYO2-4IQ::HIS3 smy1-15::TRP1 ABY4300 
ABY4314 MATa MYO2-4IQ-41::HIS3 BY4741 
ABY4315 MATa MYO2-4IQ-41::HIS3 smy1-15::TRP1 ABY4314 
ABY4304 MATa MYO2-4IQ-3GFP::URA3 BY4741 
ABY4305 MATa MYO2-4IQ-3GFP::URA3 smy1-15::TRP1 ABY4304 
ABY4316 MATa MYO2-4IQ-41-3GFP::URA3 BY4741 
ABY4306 MATa MYO2-4IQ-41-3GFP::URA3 smy1-15::TRP1 ABY4316 
 
Table 4, Plasmids used in this study 
 
Name Insert Backbone Marker  
3471 GFP-Sec4 pRS306 URA3 
2589 Sec4ΔCC (prenylation site deleted) pBridge TRP1 
LCB109 SMY1 pRS316 URA3 
LCB13 SMY1 KLD-3GFP (aa1-382) pRS316 URA3 
LCB14 SMY1 CC-3GFP (aa-436-562) pRS316 URA3 
LCB15 SMY1 MBD-3GFP (aa562-657) pRS316 URA3 
LCB16 SMY1 KLD+CC-3GFP (aa1-562) pRS316 URA3 
LCB17 SMY1 CC+MBD-3GFP (aa436-656) pRS316 URA3 
LCB18 SMY1 KLD+MBD-3GFP pRS316 URA3 
LCB45 Smy1 CC+MBD (aa436-656) pGBKT7 TRP1 
2579 myo2cctail-12 pGADT7 LEU2 
LCB54 myo2cctail-41 pGADT7 LEU2 
LCB70 myo2cctail-57 pGADT7 LEU2 
LCB102 smy1-12 YEp351 LEU2 
LCB104 smy1-15 YEp351 LEU2 
LCB98 Smy1-K+C YEp351 LEU2 
LCB99 Smy1-C+M YEp351 LEU2 
LCB43 Sec4 YEp351 LEU2 
LCB106 mito-RFPff  313 HIS3 
LCB3 Myo2cctail-3GFP 306 URA3 
1643 Myo2-4IQ 303 HIS3 
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Chapter III 
 
A Novel Rho GAP GYM1 Mediates Myo2 Dependent Secretory Vesicle Transport by 
Downregulating the Rho3 Activity  
 
Overview 
 
Small molecular weight GTPase proteins such as members of the Ras, Rho and Rab families 
play central roles in regulating cell growth, polarity, morphogenesis, neural development, 
cytoskeletal dynamics, vesicle trafficking, and more. As discussed in Chapter I, the Rab GTPase 
Sec4 associates with Myo2 for secretory vesicle transport in budding yeast. Together with Sec4, 
Smy1 is involved in coupling secretory vesicles with the Myo2 tail. Conditional mutation of the 
smy1 in mutant myo2 background showed that temperature sensitive myo2 smy1 mutants fail to 
couple secretory vesicle with the Myo2. By screening for overexpression suppressors of myo2 
smy1 mutants, we hoped to recover proteins potentially involved in Myo2 secretory vesicle 
transport. Interestingly we discovered an uncharacterized ORF that contains a Rho GAP 
domain in its C-terminus. We named the ORF, Gym1 (Gap with Yeast Myo2). Gym1 
colocalizes with Myo2 in the bud and its localization is dependent on Myo2 polarity. 
Consistent with this, Gym1 interacts with the Myo2 coiled-coil domain and it stimulates the 
hydrolysis of Rho3-GTP to Rho3-GDP. The catalytic activity is crucial in suppressing the myo2 
smy1. Our finding provides the possibility that there is an interplay between Rho and Rab 
GTPases in the transport of secretory vesicles.  
 
Materials and Methods 
 
Yeast strains and transformation 
Yeast strains and plasmids used in this study are listed in Table 5 and 6. Standard media and 
techniques for yeast growing and transformation were used and referred to Chapter II Methods 
(Sherman, 1991).  
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SGal-URA plate preparation 
1L of agar media (SGal-URA) was prepared [6.7g YNP (Yeast Nitrogen Peptone), 1.3g SD-
URA (Ura dropout in synthetic amino acids, 20g raffinose, 20g galactose and 20g agar) and 
autoclaved. Autoclaved media was allowed to become warm before pouring into petridish 
plates.  
 
cDNA Library screening for myo2 smy1 mutants  
1ug of the GAL1-cDNA library (5ul of 200ng/ul cDNA library stock) was transformed into 
overnight culture (5ml) (OD600 = ~ 0.8) (Liu et al., 1992). After incubation at 42˚C for 45 
minutes, the transformants were washed with dH2O once, transferred to a 15ml falcon tube 
and resuspended in 5.1 ml of dH2O. 100ul of resuspended transformants were spread onto 
each SGal-URA plate (50 plates x 0.1ml = 5ml) and incubated at 26˚C overnight to allow 
cDNA expression. The remaining 100ul of the transformants was spread on to one SD-URA 
plate and incubated at 26˚C for 5 days to serve as a control for the number of transformants. 
50 Plates except the control plate were transferred to 35˚C the next day and incubated for 5 
days. 80,000 transformants were screened against the myo2-41 smy1-15 mutant, and 150,000 
transformants against the myo2-57 smy1-12 mutant. The cDNA plasmids were recovered from 
the transformants and sequenced to identify the gene. 
 
Plasmid construction 
The integrating plasmids pRS306 GFP-Sec4 (URA3) and pRS306 Myo2cctail-3GFP (URA3) 
used to tag Sec4 and Myo2 have been described (Donovan and Bretscher, 2012). To create 
pRS315 Gym1-RFP construct, the RFP fragment was initially cloned between BamHI and NotI 
and terminator ADH1 (tADH) was cloned between NotI and SacII in the pRS315 backbone. 
The fragment that contains the Gym1 endogenous promoter (~ 250bp) and Gym1 full length 
(2355bp without the stop codon) was cloned between the ApaI and XmaI in the pRS315 RFP-
tADH vector. To create an integrating Gym1-RFP (i.e., pRS305 Gym1-RFP), two homologous 
regions were designed. In order to tag RFP at the C-terminus, the first cassette (Gym1-C-
terminus+RFP) was cloned between HindIII and SacII in pRS305 vector. The forward primer 
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corresponding to genomic Gym1 sequence starting at near its C-terminus 5’ 
ATTAAGCTTGCACAACTGCCACAGGAAAC 3’ and the reverse primer corresponding to 
tADH 5’ ATTCCGCGGAGGAAAGAGTTACTCAAGAA 3’ were designed. Underlined 
nucleotides indicate respective restriction site and ATT was added to aid efficient cleavage. The 
cassette was amplified from the pRS315 Gym1-RFP-tADH construct. The second homologous 
region corresponding to Gym1 3’UTR, using the primers (5’ 
ATTCTCGAGGATGTTCGTTAAAAGCTGCA 3’) and (5’ 
ATTAAGCTTCTATTAGAATCTGGGAAGTG 3’) was cloned between XhoI and HindIII. The 
integrating Gym1-RFP was linearized by HindIII before transformation.  
 
Microscopy 
Micrographs were acquired on a CSU-X spinning disc confocal microscopy system (Intelligent 
Imaging Innovations) with a DMI 6000B microscope (Leica), 100x1.45 NA objective and a 
QuantEM EMCCD camera (Photometrics) or an HQII CCD camera (Photometrics) with 2x 
magnifying lens. All images shown are maximum projection of 10 confocal slices taken 0.28 
µm apart, unless stated otherwise. Images were analyzed and processed with Slidebook 6.0 
software (Intelligent Imaging Innovations). The images were further adjusted in Photoshop 
(Adobe) to give the clearest presentation of the results and assembled in Illustrator (Adobe). 
For live-cell imaging of yeast cells, cells were attached to a glass-bottomed dish coated with 
Concanavalin A (EY laboratories) and washed with respective cell medium. Imaging at high 
temperatures was performed in an environmental chamber (Okolab).  
 
Yeast two-hybrid constructs and analysis 
The coding sequence for Myo2cctail (2776-4725nt) was fused with the GAL4 DNA activation 
domain in pGADT7 vector between NdeI and BamHI. The full length Gym1 (1-785aa) was 
fused with GAL4 DNA activation domain in pGADT7 vector between XmaI and XhoI. Each of 
all Rho proteins (Rho1, Rho2, Rho3, Rho4, Rho5, Cdc42) were fused with GAL4 DNA binding 
domain in pGBKT7 vector between XmaI and PstI without their C-terminus CXC box to 
prevent prenylation. The AH109 strain co-transformed with both plasmids was selected in 
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media lacking leucine and tryptophan (SD-2DO: double dropout). Interaction was detected by 
growth on medium lacking leucine, tryptophan and histidine (SD-3DO: triple dropout) or (SD-
3DO: triple dropout + 1mM 3AT to be more stringent in protein-protein interaction).  
 
Purification of GST-Rho and SUMO-Gym1(GAP::495-785aa) 
Full-length Rho proteins (Rho1, Rho2, Rho3, Rho4, Rho5, and Cdc42) were tagged with GST 
in their N-termini, using the pGEX-6p3 vectors. The GAP domain (495-725aa) of Gym1 was 
tagged with SUMO (Table 6). Constructs were expressed in RosettaTM 2(DE3) pLysS 
competent cells separately. Cells were grown in terrific broth with antibiotics Ampicilin 
(100ug/ml) and chloramphenicol (34ug/ml) until A600=1.0. 1mM IPTG was added to induce 
protein expression overnight. Bacterially expressed SUMO-Gym1 was selected on a Ni2+ resin. 
GST-Rho proteins were isolated by glutathione beads and GST was later cleaved by 3Cpro.  
 
Gym1 and Rho3 Antibody generation 
Gym1 (495-725aa) tagged with SUMO and Rho3 with GST tag were expressed in RosettaTM 
2(DE3) pLysS competent cells separately. Bacterially expressed SUMO-Gym1 was selected on a 
Ni2+ resin, and the SUMO tag was cleaved with Ulp1. The SUMO-cleaved Gym1p was gel 
purified and sent to Pocono Rabbit Farm and Laboratory, PA for antibody production. 
Similarly, GST-Rho3 was isolated by glutathione beads and GST was later cleaved by 3Cpro. 
Gel purified Rho3 was sent for antibody production.  
 
Immunoblotting 
Overnight cultures were harvested and resuspended in disruption buffer (20mM Tris-CL, pH 
7.9, 10mM MgCl2, 1mM EDTA, 5% glycerol, 1mM dithiothreitol, 0.3M ammonium sulfate, 
1mM PMSF, and 1x Sigma yeast protease inhibitor cocktail) with 0.1g acid-washed glass beads 
(Sigma-Aldrich, St. Louis, MO, USA). Vigorous vortexing was done at 4˚C for 3 times with 1 
minute each and 1 minute in between resting on ice. The crude lysates were centrifuged at 
17,000 g in a table-top centrifuge in a cold room (4˚C) for 10 minutes and supernatant was 
collected. For temperature sensitive strains, cells were grown at 26˚C overnight, and adjusted 
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to log phase OD600=0.8 the next day. Cells were then shifted to 35˚C for 2 hours. Upon 
harvesting, cells were chilled on ice, washed twice with ice-cold water, frozen in dry ice and 
stored at -80°C. The concentrations of protein samples were measured using Bradford assay. 
The samples were resolved by SDS-PAGE, transferred to Immobilon-P membrane (Millipore), 
then blocked for 1 hour in 5% milk in PBS-T (0.1% Tween). Membranes were incubated with 
primary antibodies for 1 hour: mouse monoclonal anti-GFP antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), or rabbit polyclonal antibodies against Myo2tail, Gym1 
and Rho3 (generated in the lab). After washing, membranes were incubated with secondary 
antibodies: IRDye goat anti-mouse and donkey anti-rabbit antibodies. Membranes were 
analyzed using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA).  
 
Coimmunoprecipitation 
Total yeast protein extracts were prepared using the same protocols described above. 10μl of 
GFP-Trap® resin (ChromoTek) was used for 1mg of each cell lysate and agitated at 4˚C for 2 
hours. Bound protein was eluted with 50μl hot (95°C) SDS-PAGE loading buffer. Eluted 
proteins were resolved on 7-15% split SDS gels.  
 
Genetic interaction by Tetrad dissection 
Genetic interaction between gym1Δ and temperature sensitive mutants (myo2-66, myo2-12, sec2-
41, sec4-8, sec6-4, sec9-4 and sec15-1) and non-essential genes (mmr1Δ, smy1Δ and rgd1Δ) was 
tested by dissecting tetrads after sporulation. Cells with opposite mating types were grown 
together overnight at 26˚C for mating. Mating efficiency was checked by shmoo projection and 
zygote formations the next day under the light microscope. Cells were washed with PBS and 
resuspended in sporulation media (1% yeast extract, 1% potassium acetate, and 0.05% 
glucose) and grown for 4-5 days. Tetrads formations were checked under light microscope. 
25ul of zymolyase (1mg/ml) was added to 50ul of sporulated cells. Zymolyase treated cells 
were incubated at 37˚C for 5 minutes. Tetrads were dissected using MSM Singer instruments 
with 50um fiber needle.  
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GTPase activity assay  
Malachite buffer (50mM HEPES, pH 7.5, 100mM KCL, 5mM EDTA, 10mM MgCl2) was 
prepared for any adjustment of the protein volume. To prepare malachite reagent, one volume 
of 0.045% (w/v) Malachite Green oxalate, FW927.02 (Alfa Aezea #A16186) was added to two 
volumes of 4.2% (w/v) Ammonium Molybdate in 4M HCL and 0.01% (v/v) of Tween20 was 
added before use to prevent precipitation. For intrinsic GTPase activity assay, 10μM of Rho3 
protein (GST cleaved) was treated with varying concentrations of GTP (10μM – 100μM) in 
nucleotide exchange buffer (50 mM Tris, pH 7.5, 100 mM KCl, 5mM DTT, 15 mM EDTA) in 
100μl volume and incubated at 30˚C for 30min. MgCl2 was added to a final concentration of 
12.5mM to stop the reaction. 100μl of malachite reagent (1:1) was added. Released phosphate 
was detected by color change at absorbance 620nm, using 96-well plate reader. Minimum three 
duplicate experiments were done. The reaction time was calculated by phosphate released 
upon varying concentrations of GTP. The values of Km and Vmax were obtained by fitting the 
data in Michaelis-Menton equation (nonlinear regression curve fitting) in GraphPad Prism 6.0. 
(GraphPad software, Inc).  
 
Stimulation of Rho GTPases activity by Gym1 
GTPase activity of Rho3 in the presence of Gym1 was tested by malachite green assay. 10μM of 
Rho3 was nucleotide-exchanged with varying concentrations of GTP (10 – 100μM) and 
incubated at 30˚C for 30min. MgCl2 was added to a final concentration of 12.5mM to stop the 
reaction. 3μM of SUMO-Gym1 (495-785aa) was added and incubated at 30˚C for 30min. 
Malachite reagent (1:1) was added and absorbance at 620nm was read at 96-well plate reader.  
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Table 5, Yeast strains used in this study 
 
Strain Genotype Parent 
BY4741 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  
BY4742 MATαlpha his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0  
ABY4035 smy1∆::KanR his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 BY4741 
ABY3313 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 trp1∆::KanR BY4741 
ABY4007 MYO2-3GFP::URA3 trp1∆::KanR ABY3313 
ABY4009 MYO2-3GFP::URA3 smy1∆::KanR ABY4035 
ABY4143 GFP-Sec4::URA3 trp1∆::KanR ABY3313 
ABY4144 GFP-Sec4::URA3 smy1∆::KanR ABY4035 
ABY3320 MATa myo2-41::HIS3 smy1-15::TRP1 trp1Δ::KanR ABY3319 
ABY3351 MATa myo2-57::HIS3 smy1-12::TRP1 trp1Δ::KanR ABY3316 
ABY2766 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆ AH109a 
ABY3451 MATα his4-619 ura3-53 sec23-1 MYO2-3GFP::URA3 RSY281 
ABY824 MATα his4-619 ura3-53 sec23-1 RSY281 
ABY2702 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 myo2-12::HIS3 BY4741 
ABY127 MATa ura3-52 sec4-8 NY405 
ABY4230 MYO2-3GFP::URA3 GYM1-RFPff::LEU2(CEN) BY4741 
ABY4231 GFP-SEC4::URA3 GYM1-RFPff::LEU2(CEN) BY4741 
 gym1∆::KanR his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 BY4741(∆ consortium) 
ABY4241 gym1∆::KanR MYO2-3GFP::URA3  
ABY4242 gym1∆::KanR GFP-SEC4::URA3  
ABY4279 Myo2-12-3GFP::URA3 GYM1-RFPff::LEU2(CEN) ABY3423 
ABY4281 Sec23-1 MYO2-3GFP::URA3 GYM1-RFPff::LEU2(CEN) ABY3439 
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Table 6, Plasmids used in this study 
 
Name Insert Backbone Marker  
3471 GFP-Sec4 pRS306 URA3 
2589 Sec4ΔCC (prenylation site deleted) pBridge TRP1 
LCB128 Rho1 (EcoRI-NotI) pGEX-6p3 AMP 
LCB129 Rho2 (EcoRI-NotI) pGEX-6p3 AMP 
LCB130 Rho3 (EcoRI-NotI) pGEX-6p3 AMP 
LCB131 Rho4 (EcoRI-NotI) pGEX-6p3 AMP 
LCB132 Rho5 (EcoRI-NotI) pGEX-6p3 AMP 
LCB133 Cdc42 (EcoRI-NotI) pGEX-6p3 AMP 
LCB135 Gym1 YEp352 URA3 
LCB136 Gym1-GAP (490-785aa) pE-SUMO AMP 
LCB137 Gym1-dead GAP (R546A) (490-785aa) pE-SUMO AMP 
LCB127 Gym1-RFP 305 HIS3 
LCB3 Myo2cctail-3GFP 306 URA3 
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Results 
 
Identification of myo2 smy1 suppressors 
 
Previously we characterized the role of Smy1 in the association of Myo2 with secretory vesicles 
by studying the myo2 smy1 mutants that were generated in our lab (Figure 3.1A) (Chapter 3). 
To further identify additional proteins potentially involved in Myo2 dependent vesicle 
transport, we screened for cDNAs whose overexpression would suppress the myo2 smy1 
mutants, using the cDNA library expressed under the GAL1 promoter (Liu et al., 1992). To 
achieve full coverage of all budding yeast genes, we transformed 80,000 cDNAs and 150,000 
cDNAs into myo2-41 smy1-15 and myo2-51 smy-12, respectively. We identified a number of 
proteins, many of them involved in the secretory vesicle transport (Figure 3.1B).  
 
Myo2-related cDNAs and Rab GTPases suppress myo2 smy1 mutants 
 
We hypothesized that identification of the myo2 smy1 suppressors should reveal proteins 
potentially involved in the vesicle transport because the myo2 smy1 mutants fail to transport 
secretory vesicles (Lwin et al., 2016). We confirmed that all our cDNAs suppressed myo2-41 
smy1-15 (Figure 3.2A). Characterization of all cDNA candidates supported our hypothesis. 
Calmodulin (CMD1), and Myosin Light Chain (MLC1) are involved in the regulation of myosin 
conformation (Brockerhoff et al., 1994; Terrak et al., 2005). Calmodulin Kinase (CMK1) also 
suppresses the myo2-41 smy1-15. The Smy1 and Rab GTPases such as Sec4, Ypt31/32 are 
involved in activating and coupling the Myo2 motors with secretory vesicles (Figure 3.2A) 
(Stevens and Davis, 1998; Wagner et al., 2002). Only a few cDNAs: YHR182W, MLC1, SMY1, 
and YPT31 suppressed the myo2-57 smy1-12, presumably due to the presence of critical 
mutations (Y1415S together with other two alleles) in the Rab binding site (Figure 3.2A). 
Interestingly, we discovered a new hypothetical protein YHR182W, which we named as GYM1 
in this study. However, deletion of GYM1 has no overt phenotype (Figure 3.2, C and D).  
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Figure 3.1. Identification of temperature sensitive myo2 smy1 suppres-
A
B
Figure 3.1. Identification of temperature sensitive myo2 smy1 suppressors
(A) Growth of temperature sensitive strains: myo2-41 smy1-15 and myo2-57 smy1-12. 10-fold serially diluted cells spotted on YPD 
plates and incubated at 26˚C and 35˚C for 2 days. 
(B) A list of cDNA candidates from overexpression suppression screening of myo2-41 smy1-12 (80,000 cDNAs coverage) and myo2-57 
smy1-12 (150,000 cDNAs coverage).
Genes Description
Calmodulin; Ca++ binding protein that targets Nuf1p, Myo2p and calcineurin.
Calmodulin-dependent protein kinase; may play a role in stress response.
Light chain for Myo2p; stabilizes Myo2p by binding to the neck region.
Rab family GTPase; essential for vesicle-mediated exocytic secretion and autophagy.
Kinesin-like myosin passenger-protein; interacts with Myo2p.
Aka KNR4; Protein involved in the regulation of cell wall synthesis.
Rab family GTPase; mediates intra-Golgi traffic or the budding of post-Golgi vesicles. 
Rab family GTPase; mediates intra-Golgi traffic or the budding of post-Golgi vesicles. 
CMD1
CMK1
MLC1
SEC4
SMY1
SMI1
YPT31
YPT32
Overexpression suppression of myo2-41 smy1-15 
Genes Description
Light chain for Myo2p; stabilizes Myo2p by binding to the neck region.
Putative protein localizes to the cell periphery and cytoplasm, Rho GAP protein.
Rab family GTPase; mediates intra-Golgi traffic or the budding of post-Golgi vesicles. 
MLC1
YHR182W
YPT31
Overexpression suppression of myo2-57 smy1-12
Clones
3/25
1/25
3/25
2/25
1/25
6/25
8/25
1/25
Clones
1/8
1/8
6/8
MYO2 SMY1
myo2-41
smy1-15 
myo2-41 smy1-15
myo2-57
smy1-12
myo2-57 smy1-12
26°C 35°C
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Gym1 is localized in the bud and its localization is dependent on Myo2 polarization 
 
To localize Gym1, I tagged it with RFP. Gym1-RFP colocalized with the Myo2 motors (Myo2-
3GFP) in the bud, together with the secretory vesicles marked by GFP-Sec4 (Figure 3.2B). 
Deletion of Gym1 had no effect on the polarity of Myo2 motors and secretory vesicles overall 
(Figure 3.2D). To test whether Gym1 localization is dependent on Myo2 or Sec4, I used myo2-
12 mutant, in which myo2-12-3GFP was still polarized and secretory vesicles (GFP-Sec4) failed 
to polarize at the restrictive temperature. In myo2-12, I found that Gym1 was still polarized at 
both permissive (26˚C) and restrictive (37˚C) temperatures (Figure 3.3, A, B and C), 
indicating that Gym1 polarity was not dependent on Sec4 or secretory vesicles. To further 
characterize if Gym1 localization was dependent on the Myo2 polarity, we used the conditional 
sec23-1 mutant. In sec23-1 when shifted to the restrictive temperature for 1 hour, Myo2 failed to 
polarize in the bud due to lack of secretory vesicle formation at the early secretory stage 
(Donovan and Bretscher, 2012). We observed that Myo2 and Gym1 failed to polarize in sec23-1 
at the restrictive temperature, which suggested that Myo2 polarity was required for the 
localization of Gym1 in the bud (Figure 3.3, D and E). These results suggest that Gym1 
localization in the bud is dependent on the Myo2 polarity.  
 
Gym1 interacts with the Myo2 coiled-coil domain and its full-length is required for its 
localization 
 
Because Gym1 colocalized with the Myo2 motors and its localization was dependent on Myo2, 
we studied the interaction between Gym1 and Myo2. Yeast-two hybrid showed that Gym1 
interacted with the Myo2 coiled-coil domain (Figure 3.4A). Immunoprecipitation of Myo2-
FLAG pulled down the Gym1-3GFP, indicating that this interaction might account for their 
colocalization (Figure 3.4B). We also explored the possibility of Smy1 and Sec4 interaction 
with Gym1. Neither of these interacted with the Gym1 (Figure 3.4, C and D). Both active GTP-
bound and inactive GDP-bound Sec4 (Sec4Q74L and Sec4S34N) failed to interact with Gym1 
(Figure 3.4D). We also further characterized which domain of Gym1 was localized in the bud. 
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Figure 3.3. Gym1p is localized in the bud and its localization is dependent on Myo2 polarity
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Figure 3.3. Gym1 is localized in the bud and its localization is dependent on Myo2 polarity.
(A) and (B) Localization of Myo2, Gym1 and Sec4 in the indicated strains at 26°C or after shifting to 37°C for 1hr. Scale bars, 2μm.
(C) Quantification of small budded (≤ 2μm) cells with polarized Myo2, Gym1 and Sec4 at 26˚C and 37˚C. Mean values are from three 
independent experiments (n=50 each) and error bars indicate SD. 
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Figure 3.3. (Continued) Gym1p is localized in the bud and its localization is dependent on Myo2 polarity
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Figure 3.3. (continued) Gym1 is localized in the bud and its localization is dependent on Myo2 polarity.
(D) Localization of Myo2 and Gym1 in sec23-1 at 26°C or after shifting to 37°C for 1hr. Scale bars, 2μm.
(E) Quantification of small budded (≤ 2μm) cells with polarized Myo2 and Gym1 at 26˚C and 37˚C. Mean values are from three indepen-
dent experiments (n=50 each) and error bars indicate SD. 
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We created five constructs; each of which had about 200 to 300aa residues that were tagged 
with 3GFP, and their protein expressions were checked (Figure 3.4, E, F and G). Only full 
length Gym1 showed the polarity of Gym1, which indicated that none of the regions examined 
was sufficient for its localization (Figure 3.4 G).  
 
Gym1 has a C-terminal Rho GAP domain and the critical arginine residue is necessary 
for its suppression activity   
 
Gym1 has a putative Rho GTPase Activating Protein (GAP) domain in the C-terminal region of 
the protein. GAP proteins have highly conserved domains that facilitate the intrinsic GTPase 
hydrolytic activity of their respective GTPases such as Ras, Rho, and Rab proteins (Scheffzek et 
al., 1998). Rho GAP domains have a highly conserved arginine residue within the consensus 
motif. The arginine residue, which contacts the nucleotide-binding site, facilitates the 
hydrolysis of the bound GTP (Scheffzek et al., 1998). Budding yeast Rho GAPs have conserved 
GAP domains, characterized by motif 1 and motif 2 (Roumanie et al., 2001). To examine if 
Gym1 has Rho GAP activity, we aligned the Gym1 sequence with the budding yeast Rho GAPs: 
Bag7, Sac7, Rga1, Rga2, Bem2, Bem3, and Rgd1, using the clustalW2 alignment program. The 
arginine residue of Gym1 lies at the position 546 (Figure 3.5A). Mutation of the arginine to 
alanine lost the suppression activity of the Gym1 for myo2 smy1 mutants (Figure 3.5, B and C). 
However, mutation of the lysine 519 to alanine (K519A) did not affect the Gym1 
overexpression suppression activity, indicating that the arginine residue at the 546aa position 
was critical for Gym1 GAP activity. This finding suggests that Gym1 suppression on myo2 smy1 
mutants is dependent on its GAP activity.  
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Rho GAP, Gym1, stimulates the Rho3 GTPase activity 
 
Rho proteins have intrinsic GTPase activity, which catalyzes the bound GTP into GDP, 
releasing inorganic phosphate (Pi). The hydrolytic activity, however, is slow in the absence of 
Rho GAPs (GTPase Activating Proteins). By facilitating GTP hydrolysis, Rho GAPs play an 
important role in down-regulating the activity of Rho proteins. Because Gym1 has a Rho GAP 
domain, we examined which Rho proteins interact with Gym1 in budding yeast. We tested all 
Rho proteins: Rho1, Rho2, Rho3, Rho4, Rho5, and Cdc42. By examining the yeast-two hybrid 
interaction, we found that Gym1 interacted with Rho3 (Figure 3.6A).  
 
We also investigated the specificity of the Gym1 GAP activity biochemically. SUMO-Gym1 
(GAP domain: 495-785aa) and GST-Rho proteins were expressed in bacteria and purified 
(Figure 3.6B). By using a colorimetric malachite green assay, which detects inorganic 
phosphate in the assay, we observed that Gym1 specifically stimulated the hydrolytic activity of 
Rho3 (Figure 3.6, C, D and E). Rho3 has an intrinsic Km value at 123µM and Gym1 stimulates 
the GTPase activity of Rho3 by tenfold, which reduces the Km value at 12 ± 1.9 µM (Figure 
3.6F). We also showed that Gym1 dead mutant, R546A allele, failed to stimulate the Rho3 
(Figure 3.6G). This finding showed that Gym1 GAP activity is specific to Rho3 and the activity 
is important in restoring Myo2 dependent vesicle transport in the myo2-41 smy1-15 mutant.   
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Figure 3.7. Rho3 and Rho3 specific Gym1 are involved in Myo2 dependent secretory pathway.
A
B
Vector
Gym1 vector
Gym1 Rho1
Gym1 Rho2
Gym1 Rho3
Gym1 Rho4
Gym1 Rho5
Gym1 Cdc42
26°C 35°C2μ
myo2-41 smy1-15
YPD rgd1∆::G418gym1∆::HIS3
YPD+G418SD-his3
A
B
C
D
E
A
B
C
D
E
Tetrad
gym1∆::HIS3
rgd1∆::G418
NPD = double delete:: gym1∆::HIS3, rgd1∆::G418
NPD = WT::GYM1, RGD1
D
Figure 3.7. Rho3 and Rho3 specific Gym1 are involved in Myo2 dependent secretory pathway.
(A) Overexpression of Rho1, Rho3 and Cdc42 specific GAPs on myo2-41 smy1-15. *Rgd1 is GAPs for both Rho3 and Rho4. 
(B) Gym1 and Rgd1 has no genetic interaction confirmed by tetrad analysis. YPD = Yeast Peptone Dextrose plate, NPD = non-parental ditype: WT or 
gym1Δ rgd1Δ. 
(C) Phalloidin staining of F-actin in Rho3 GAP mutants: gym1Δ, rgd1Δ and double mutant gym1Δ rgd1Δ. Scale bar, 2μm.
(D) Genetic interaction tested by overexpressing Gym1 and Rho protein in myo2-41 smy1-12 ts mutant.
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Gym1 is the only RhoGAP that suppresses myo2 smy1 mutants 
 
Yeast has a total of seven RhoGAP proteins: Bag7, Lrg1, Sac7, Rga1, Rga2, Rgd1 and now 
Gym1. Bag7, Lrg1 and Sac7 are Rho1 specific GAPs; Rga1 and Rga2 are Cdc42 specific GAPs 
(Smith et al., 2002), and Rgd1 is a GAP for both Rho3 and Rho4 (Doignon et al., 1999). We 
observed that Gym1, which is the only Rho3 specific GAP, suppressed the myo2 smy1 mutants, 
indicating that Gym1 and Rho3 are specifically involved in the secretory vesicle transport 
(Figure 3.7A).  
 
Because Rgd1 is a Rho3 GAP (Doignon et al., 1999), we examined if genetic interaction exists 
between Gym1 and Rgd1. Tetrad analysis showed that gym1Δ and rgd1Δ grow well as does 
gym1Δ rgd1Δ (Figure 3.7B), which suggested that Gym1 and Rgd1 could have different GAP 
activities, spatially and temporally, or another potential Rho3 GAP exists. We further explored 
the possibility of Rgd1 and Gym1 in the formation of actin filaments because Rho proteins are 
involved in actin organizations (Goode and Eck, 2007). Phalloidin staining of F-actin in gym1Δ, 
rgd1Δ and gym1Δ rgd1Δ showed no defect in formation of the actin filaments (Figure 3.7C).  
 
We used an additional genetic approach to test the specificity of Gym1 for Rho3. The current 
data suggest that Gym1 overexpression suppresses the myo2-41 smy1-15 mutant by deactivating 
Rho3-GTP. If this is correct, overexpressing both GYM1 and RHO3 in the mutant might 
abrogate the suppression. We therefore overexpressed each of the Rho proteins in myo2-41 
smy1-15 cells that also had Gym1 overexpressed. Only RHO3 overexpression could reverse the 
suppression conferred by GYM1, further indicating a functional relationship between Gym1 and 
Rho3 (Figure 3.7D).   
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Discussion 
 
Myosin motors are evolutionarily conserved proteins across eukaryotic species. Extensive 
studies on skeletal myosin have shed light on how myosin motors coordinate their step-wise 
movement on actin filaments (Vale, 2003). Similarly, budding yeast myosin-V, Myo2, also 
opened an interesting field of motors and cargos transport (Hammer and Sellers, 2012). Yeast 
myosin-V utilizes different receptors to recognize its specific cargos: Rab GTPase Sec4 for 
secretory vesicles (Jin et al., 2011); Mmr1 or Ypt11 for mitochondria (Chernyakov et al., 2013; 
Itoh et al., 2004); Inp2 for peroxisome (Fagarasanu et al., 2006) and Vac17/Vac8 for vacuole 
inheritance (Ishikawa et al., 2003). As organisms evolve, many proteins become redundant and 
yet provide the same function. For example, Smy1 is a non-essential protein. Deletion of Smy1 
has no growth phenotype or effect on other proteins in the secretory vesicle transport (Lwin et 
al., 2016). Overexpression of Smy1, however, rescued myo2 mutants such as myo2-66 (Lillie 
and Brown, 1992), which was defective in secretory vesicle transport. This rescue phenotype 
supported the evolutionary role of the Smy1 in the secretory vesicle transport. We have 
previously shown that Smy1 enhances the Myo2 coupling with secretory vesicle receptor Rab 
GTPase Sec4 (Lwin et al., 2016). By using myo2 smy1 mutants in our overexpression cDNA 
screening, we hypothesized that we would uncover new factors, potentially involved in the 
Myo2 dependent secretory vesicle transport. Most of the cDNA candidates that we identified 
support our hypothesis that as most of the suppressors are Myo2-related proteins such as 
Cmd1, Cmk1, Mlc1, and vesicle-related Rab GTPases such as Sec4 and Ypt31/32. Interestingly 
Smi1 is also a suppressor, which suggests that cell wall synthesis is somehow related to the 
Myo2 dependent secretory vesicle transport.  
 
A hypothetical gene YHR182W (named GYM1 in this study) also suppressed both of our 
mutants: myo2-41 smy1-15 and myo2-57 smy1-12. We found that Gym1 was polarized in the bud 
and its polarity was dependent on Myo2. The fact that Gym1 polarity was lost in the sec23-1 
mutant indicated that Gym1 is somehow involved in the secretory vesicle transport. Yeast-two 
hybrid interaction between Gym1 and Myo2 further supported such a possibility. Analyzing the 
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Gym1 sequence returned a putative Rho GAP domain in the C-terminus (459-725aa). The N-
terminus, which occupies about 300 amino acids residues, returned no known protein domain. 
Therefore, the functional importance of Gym1 N-terminal domain  remains to be characterized.  
 
All GAP proteins have a consensus motif that contains an arginine residue. The arginine 
residue facilitates the phosphodiester bond cleavage at the last phosphate (Pγ) from the bound 
GTP, releasing inorganic phosphate. Mutation of the Gym1 arginine residue at position 546 to 
alanine resulted in suppression failure, indicating that Gym1 GAP domain was functional and 
its GAP activity was crucial in suppression. Further characterization of Gym1 on all available 
Rho proteins in budding yeast led us to show that Gym1 is specific for Rho3. Because Gym1 is 
a Rho GAP, which suppresses conditional myo2 smy1 mutants, we next investigated whether 
other Rho GAPs were also able to suppress the mutants. We observed that only Rho3 specific 
Gym1 suppressed the conditional mutants, suggesting that only Rho3 and Gym1 were possibly 
involved in the secretory vesicle transport. This opened the possibility of Rgd1, another Rho3 
GAP, involvement in other functions rather than in membrane trafficking. Our examination of 
actin filaments formation in null mutants such as rgd1Δ and gym1Δrgd1Δ indicated that Gym1 
and Rgd1 had no effect on actin organization. This could also suggest that another potential 
Rho3 GAP exists or Gym1 and Rgd1 have different GAP functions on Rho3, spatially and 
temporally.  
 
In summary, our finding showed that Gym1 mediated the vesicle trafficking in a Myo2 
dependent manner through Rho3 GTPase. It is also interesting to note that the majority of 
GTPases in vesicles trafficking are Rab GTPases (Hutagalung and Novick, 2011). Our data 
suggest that Rho3 is a negative regulator of the association of Myo2 with secretory vesicles. 
Because Myo2 also undergoes activation by a Rab protein and needs to recycle so as to 
transport cargo as necessary, it is possible that Rho3 is crucial in regulating the Myo2 recycling 
process. The question of how Rho3 regulates Myo2 recycling remains to be answered. The 
Rho-related protein TC10 in mammalian cells is also involved in transporting insulin induced 
GLUT4 transporter, CFTR receptor to the plasma membrane, and its GTP hydrolysis is 
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required for exocytic vesicle fusion (Cheng et al., 2005; Chiang et al., 2001; Inoue et al., 2003; 
Kawase et al., 2006). Therefore, our finding in budding yeast regarding the Rho GAP suggests 
a strong possibility that there is an interplay between Rho and Rab GTPases in vesicle 
trafficking and cargo transport.  
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Chapter IV 
 
Summary and Future Directions 
 
 
Ever since George Palade opened an era of research into protein secretion in the 1960s, 
many researchers devoted their scientific endeavors to understanding cellular mechanisms of 
protein secretion (Jamieson and Palade, 1967a; Jamieson and Palade, 1967b; Jamieson and 
Palade, 1968). It became apparent that several coordinated steps were involved in the secretory 
vesicle transport when Randy Schekman and Peter Novick showed their seminal work in 
vesicle secretion in budding yeast (Novick et al., 1981; Novick et al., 1980; Novick and 
Schekman, 1979). The Novick lab contributed much to the understanding of a ras-like protein, 
Sec4, which was later known as the master regulator of the late secretory pathway (Salminen 
and Novick, 1987; Walworth et al., 1989). Johnston et al., showed that myosin motor, Myo2 is 
essential in late secretory stage (Johnston et al., 1991). Connecting these two dots, the 
Bretscher lab showed that the tail domain of Myo2 was essential for transporting secretory 
vesicles, marked by Sec4 Rab GTPase (Schott et al., 1999). A clear understanding of receptors-
mediated cargo transport became available when the Weisman lab crystallized the Myo2 tail 
domain and showed that several receptor-binding sites existed on the Myo2 tail (Eves et al., 
2012; Pashkova et al., 2006). Myo2 motor behavior in vesicle transport also became clear after 
Donovan and Bretscher showed that the Myo2 motor underwent conformational changes upon 
vesicle binding and several steps were involved in both transporting and releasing the secretory 
vesicles at the plasma membrane (Donovan and Bretscher, 2012; Donovan and Bretscher, 
2015a; Donovan and Bretscher, 2015b). 
 
Within a span of 50 years, we became more knowledgeable about the secretory vesicle 
transport because more and more proteins were discovered and their functions were 
successfully characterized. Before I summarize our findings on Smy1 functions and subsequent 
discovery of Gym1, I would like to take a moment and mention here that research on Smy1 
function since its discovery in 1992, has been very minimal with 10 published studies so far. 
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Four seminal papers from Lillie and Brown paved the way for Smy1 potential functions 
(Beningo et al., 2000; Lillie and Brown, 1992; Lillie and Brown, 1994; Lillie and Brown, 1998). 
The Trybus group found that Smy1 increased the processivity of Myo2 motors (Hodges et al., 
2009). The Goode lab later claimed that Smy1 dampened the actin cable length (Chesarone-
Cataldo et al., 2011). The two major functions of the Smy1, claimed by both Trybus and Goode 
labs, failed to explain why the overexpression of Smy1 suppressed the myo2-66 mutant. The 
myo2-66 mutant has a defect in the secretory vesicle transport, and it was the mutant in which 
Smy1 was discovered by overexpression suppression screening.  
 
Based on several potential functions of Smy1, being a non-essential protein to begin 
with, much of our earlier effort was dedicated to creating conditional smy1 mutants so that we 
could study the molecular function of the Smy1 in detail. To summarize Smy1 functions from 
Chapter II, I would like to highlight our finding that Smy1 stabilizes the interaction between 
Myo2 tail and vesicle receptor Sec4 Rab GTPase. Our finding answered why the overexpression 
of Smy1 was able to suppress temperature sensitive myo2 mutants such as myo2-66 (Lwin et al., 
2016). Due to its stabilizing effect, overexpression of Smy1 increased the average number of 
Myo2 motors associated with a secretory vesicle by 1.5 fold. In addition, by forcing the two 
receptors Sec4 and Ypt11, to compete for the same binding site on Myo2 tail for secretory 
vesicle and mitochondria transport, respectively, we showed that Smy1 specifically enhanced 
the binding of Sec4, which brought more secretory vesicles and hindered the segregation of 
mitochondria into the bud. One of the striking features we found was that reduction of the 
Myo2 lever arm from 6IQ to 4IQ in our myo2 smy1 mutants eliminated the temperature 
sensitivity of myo2 smy1 which led us to explore the possibility of the importance of Myo2 head-
to-tail interaction because shortening the lever arm would disrupt the head-to-tail interaction 
and it would probably leave the Myo2 in a constitutively active form.  
 
Several labs have shown that myosin motors have two distinct conformations: (1) open 
or extended form, and (2) closed or folded forms. Most of the structural studies were done 
with changes in calcium or salt concentration, and electron micrograph imaging (Li et al., 
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2004; Thirumurugan et al., 2006; Wang et al., 2004). How Myo2 structural changes have an 
impact on its molecular function is still unclear. Recently Donovan and Bretscher found that 
Myo2 head-to-tail interaction was critical for vesicle transport and losing such interaction was 
deleterious for cell growth (Donovan and Bretscher, 2015a). However, the mechanism that 
triggers the Myo2 to change its conformation still remains to be identified. Either the 
triggering mechanism begins from the head or tail or both domains simultaneously remains 
unanswered. From the Myo2 head domain and lever arm standpoints, several proteins, for e.g., 
calmodulin (Cmd1), myosin light chain (Mlc1), bind the lever arm. Rho3 GTPase binds the 
Myo2 coiled-coil domain and several receptors such as Sec4, Ypt31/32 Rab GTPases bind the 
Myo2 tail domain. Losing the recycling activity of the Myo2 motor due to its constitutively 
active conformation has deleterious effects on cell growth. Future research on such 
undertaking will be challenging because of the intricate nature of small molecules, necessity of 
powerful microscopes, and molecular techniques. However, investigation of such molecular 
mechanism will shed a light on our understanding of how the regulation of myosin motors is 
crucial for cell growth and subsequent cell survival.  
 
With the knowledge of Myo2 conformational change kept in mind, I came upon a 
surprising turn of event when I was screening overexpressing suppressors on our myo2 smy1 
mutants, which I detailed in Chapter III. cDNA candidates from suppressors screening include 
Myo2-related proteins such as Cmd1, Mlc1, Cmk1 and vesicle-related proteins such as Sec4, 
Ypt31/32 and Smy1. A new ORF, YHR182W, was also found in our suppressors and it was 
named Gym1. To highlight the Gym1 function, I found that Gym1 was polarized in the bud, 
and its polarity was dependent on the Myo2 localization. The suppression activity of Gym1 on 
myo2 smy1 mutants was dependent on the critical arginine R546 in its Rho GAP domain. I also 
showed that Gym1 stimulated Rho3 GTPase activity, and this activity was dependent on the 
arginine residue. Nicole et al., in 1999 showed that Rho3 interacts with the Myo2 coiled-coil 
domain and is potentially involved in exocytosis (Robinson et al., 1999). Interestingly, we also 
found that Gym1 interacts with the Myo2 coiled-coil domain. We hypothesized that Gym1 
down-regulates Rho3 activity that acts to inhibit secretory vesicle transport, thereby 
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suppressing the myo2 smy1 mutants. To test our hypothesis, we overexpressed both Gym1 and 
Rho3. Overexpression of Rho3 reversed the Gym1 suppression, indicating that Gym1 indeed 
downregulates the Rho3 activity in the secretory pathway.  
 
As of this writing, I found that Gym1 was involved in the secretory vesicle transport 
and it mediated the vesicle coupling with Myo2 by downregulating the Rho3 activity. How 
exactly Gym1 and Rho3, which bind at the Myo2 coiled-coil domain, exert their molecular 
function in the secretory vesicle transport is still unclear. One possible explanation is Rho3 
together with Sec4 in their active form, i.e., prenylated and inserted into vesicle membrane, 
facilitate secretory vesicles coupling with the Myo2 in coiled-coil and tail domain, respectively. 
However this will cause Myo2 in folded form. In order for Myo2 to extend from the folded 
form, Gym1 stimulates the Rho3 GTPase activity, which releases the bound Rho3 from the 
Myo2 coiled-coil domain and facilitates the Myo2 to extend its tail and transport vesicle.  
 
Regulation of the Myo2 conformation in the secretory vesicle transport became more 
convincing as half of all our suppressors were Myo2-related proteins such as Cmd1, Mlc1 and 
Cmk1. They all regulate Myo2 activity (Stevens and Davis, 1998). Another interesting area to 
explore is how these proteins mediate vesicles transport by changing the Myo2 conformation. 
Recently a few labs showed that myosin proteins underwent conformational change upon 
binding their respective proteins. Myo51 in fission yeast changed its conformation upon 
binding Rng8/9, which regulated its localization and function (Tang et al., 2016). MyoVa in 
mammalian cells also underwent a similar conformational change upon binding melanophilin 
(Mlph) (Zhang et al., 2016). As more structures are determined, we will come to understand 
regulation of many proteins from a structural perspective.  
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Appendix 
 
Investigating the importance of Smy1 individual domains and  
Characterization of the Smy1 binding site on Myo2 tail 
 
Overview 
 
This chapter will describe some experiments that showed interesting results that could 
stand alone and become another interesting research area to explore. Some results were 
supportive of our hypothesis and yet we did not use in our published data because they 
warrant extra experiments to prove additional hypotheses. Some results led us to interesting 
findings. Among them, Smy1 binding site on Myo2 tail remains unanswered. Basically a 
number of receptor-binding sites on Myo2 tail have been mapped with yeast-two hybrid assay 
(Eves et al., 2012). I investigated the Smy1 binding site and the importance of its individual 
domains in secretory vesicle transport. I also followed up on Gym1 genetic interactions with all 
conditional mutants, which are involved in the secretory vesicle transport.  
  
Materials and Methods 
 
Yeast strains and transformation 
Yeast strains and plasmids used in this study are listed in Table 3 and 4. Standard media and 
techniques for yeast growing and transformation were used (Sherman, 1991). Briefly, for 
transformation, 5ml of log phase OD600 = ~ 0.8 cells were harvested and resuspended in a 
mixture of 36μl of 1 M LiAc, 240 μl of 50% PEG 3350 (w/v), 50μl of salmon sperm DNA 
10mg/mL, 1μg of DNA constructs, and volume-adjustable 29 µl H2O (Gietz and Woods, 2002). 
Cells were incubated at 42˚C for 45 minutes and transformants were selected on selective 
synthetic dropout media plates. Gene deletion and chromosomal GFP tagging were performed 
by standard PCR-mediated techniques (Longtine et al., 1998). Plasmids from yeast were 
isolated using the plasmid isolation kit (YeaStar Genomic DNA kit).  
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Yeast two-hybrid constructs and analysis 
The coding sequence for Myo2cctail (2776-4725nt) was fused with the DNA activation domain 
in pGADT7 vector between NdeI and BamHI. To create point mutation in Myo2cctail, 40 
nucleotide long forward and reverse primers were designed with mutated nucleotides in the 
middle of the primers, and pGADT7-Myo2cctail was used as a template. The point mutation 
was verified after sequencing the miniprepped product from the bacteria transformants. The 
Smy1 myosin-binding domain (1308-1968nt) was fused with DNA binding domain in pGBKT7. 
The AH109 strain co-transformed with both plasmids was selected in media lacking leucine 
and tryptophan (SD-2DO: double dropout). Interaction was detected by growth on medium 
lacking leucine, tryptophan and histidine (SD-3DO: triple dropout).  
 
Glucose depletion assay 
The assay was discovered by postdoctoral associate Dr. Li Xu in Bretscher lab (Xu and 
Bretscher, 2014). Briefly, yeasts were attached to a glass-bottomed dish coated with 
Concanavalin A (EY laboratories) and washed with respective cell medium and replenished 
with media lacking glucose. Images were immediately taken since the Myo2 rigor state only 
lasts for 3-5 minutes.  
 
Genetic interaction by Tetrad dissection 
Genetic interactions between gym1D and temperature sensitive mutants (myo2-66, sec2-41, sec4-
8, sec6-4, sec9-4 and sec15-1) and non-essential genes (mmr1D, smy1D and rgd1D) were tested by 
dissecting tetrads after sporulation. Cells with opposite mating types were grown together 
overnight at 26˚C for mating. Mating efficiency was checked by shmoo projection and zygote 
formations the next day under the light microscope. Cells were washed with PBS and 
resuspended in sporulation media (1% yeast extract, 1% potassium acetate, and 0.05% glucose) 
and grown for 4-5 days. Tetrad formation was checked under the light microscope. 25μl of 
zymolyase (1mg/ml) was added to 50ul of sporulated cells. Zymolyase treated cells were 
incubated at 37˚C for 5 minutes. Tetrads were dissected using MSM Singer instruments with 
50μm fiber needle.  
 116 
Results and Discussion 
 
Chimeric Smy1tail-Sec4 suppresses myo2 ts mutants. 
 
I showed that Smy1 tail (MBD: Myosin Binding Domain) was required for binding the 
Myo2 tail and Smy1 head was involved in coupling secretory vesicles with the Myo2 in Chapter 
II. Smy1 has three distinct domains: (1) kinesin-like motor domain, (2) coiled-coil and (3) 
myosin binding domains. Interestingly, all of smy1 ts alleles recovered from our myo2 smy1 
mutants were clustered at the Smy1 head domain although we introduced random mutations 
in entire SMY1 ORF (Figure 2.2 F). The fact that none of our conditional smy1 mutations were 
localized in the Smy1 tail domain suggests that the tail domain (myosin binding domain) is 
indispensable for receiving any conditional mutations. Yeast-two hybrid showed that myo2-12 
failed to interact with the Sec4 although it still interacted with the Smy1 (Figure 4.1A). To test 
the function of individual domains of Smy1, my initial hypothesis was that the Smy1 head 
domain binds the secretory vesicle membrane through some receptor, and the tail domain 
solely functions as a myosin-binding domain. To test the idea, I created two chimeric proteins: 
(1) Smy1(head)+Sec4 and (2) Smy1(tail or MBD)+Sec4. The placement of Sec4 at the COOH 
terminus of both chimeric constructs was to make sure that Sec4 CAAX box could be properly 
prenylated (Figure 4.1B). I found that overexpression of Sec4 failed to suppress conditional 
myo2 mutants while Smy1 overexpression can (Figure 4.1, C and D), further supporting our 
initial finding on yeast-two hybrid, in which myo2-12 failed to interact with Sec4, but it still 
interacted with Smy1 (Figure 4.1A). Overexpression of the chimeric Smy1(head)+Sec4 failed 
to suppress myo2-12, presumably due to the lack of binding capacity from both proteins, i.e., 
Smy1(head) does not bind Myo2 and Sec4 in this case cannot bind myo2-12. However the 
chimeric Smy1(MBD)+Sec4 suppressed the myo2-12 mutant, which supported the idea that 
Smy1 tail now presumably compensated for the loss of Sec4 binding to myo2-12, and conferred 
the full suppression from the Sec4.  
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Figure 4.1 Chimeric Smy1(MBD)+Sec4 suppresses temperature sensitivity of myo2ts mutants.
382                             562                      656  
Kinesin like motor domain (KLD) Myosin binding domain (MBD)CC CC
382   436  463   507   562                      656  
Kinesin like motor domain (KLD) CC CC Sec4
1                                           215382             562     
Myosin binding 
domain (MBD)
CC CC Sec4
1                                           215
Vector
Myo2-cctail
myo2-12cctail
Vec Smy1
A
D
2DO
BD
Sec4 Vec
3DO
Sec4Smy1
Figure 4.1 Chimeric Smy1(MBD)+Sec4 suppresses temperature sensitivity of myo2ts mutants.
(A) Yeast two-hybrid interactions between Myo2-cctail (926-1575aa) and myo2-12-cctail fused to the activation domain (AD) and Smy1 
fused to the binding domain (BD) and Sec4 fused to the binding domain (BD). 2DO= 2 dropouts: leu and trp, 3DO = 3 dropouts: leu, 
trp, his.
(B) Chimeric constructs between Smy1 head domain (KLD+CC) and full length Sec4 or Smy1 tail domain (CC+MBD) fused to the full 
length Sec4. 
(C) Overexpression suppression of individual Smy1, Sec4 constructs and chimeric constructs 
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Smy1 binding site on Myo2 cargo-binding domain 
 
I investigated the Smy1 binding site on Myo2 tail because a number of receptor binding 
sites on Myo2 tail have been successfully identified for Sec4, Ypt31, Ypt11, Vac17, Mmr1 and 
Kar9 by yeast-two hybrid between the said receptors and point mutations on the Myo2 tail 
(Figure 4.2A) (Eves et al., 2012). In a similar fashion, I hoped to find the Smy1 binding site. 
The Weisman lab claimed that Smy1 binding site was yet to be identified. Fortunately, the 
Bretscher lab has a number of myo2 mutants: myo2-12, -13, -14, -16, -18 and -20. Interestingly 
earlier work in our lab showed that overexpression of Smy1 suppressed all aforementioned 
myo2 mutants except myo2-14 (Schott et al., 1999). A previous graduate student, Donghao Li, 
also showed that myo2-14 failed to interact with Smy1 (unpublished data). The mutant is 
temperature sensitive and fails to transport mitochondria without affecting secretory vesicle 
transport (Chernyakov et al., 2013). The myo2-14 allele has 3 mutations: Y1451D, G1461V and 
L1536amber (Figure 4.2B). The non-sense mutation truncates the last 38 amino acids in sub-
domain II completely. Thus the last 38 residues may be important for Myo2 to bind Smy1. 
 
To characterize the binding site, I created a serial truncation of Myo2 tail with 5 amino 
acids truncated each time, i.e., Myo2 tail (-5aa), Myo2 tail (-10aa), so on until the Myo2 tail (-
40aa), making a total of 8 Myo2 tail variants (Figure 4.2C). Smy1 strongly interacted with the 
Myo2 tail until the last 15 residues were truncated (Figure 4.2D). I thought this probably 
suggested that the Smy1 binding site was between residues 10 and 15. I created site-directed 
mutagenesis on residues in-between (1559, 1560, 1563, 1567, 1569, 1570aa) on full length 
Myo2 tail accordingly. Interestingly, I found no loss in Smy1 interaction but those point-
mutants failed to interact with Sec4 Rab GTPase whose binding site is in domain II (Figure 
4.2E). This suggested that Smy1 binding site on Myo2 was still elusive and the fact that Smy1 
fails to interact with Myo2 (-15aa) was not due to its loss of binding site, rather presumably 
due to some conformational change upon loss of its last residues.  
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Figure 4.2 Smy1 binding site on Myo2 cargo binding domain 
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Glucose depletion and Smy1 effect on secretory vesicle in Myo2 rigor state 
 
Since Smy1 increases the Myo2 coupling with secretory vesicles by Sec4 Rab GTPase, I 
was keen on taking advantage of the Myo2 rigor phenotype in glucose depletion, the phenotype 
of which was observed in our lab by postdoctoral associate Dr. Li Xu. Our yeast microscopic 
experiments were done in media suitable for yeast growth. Li observed that Myo2 motors, 
upon nutrient depletion in yeast media, underwent rigor state on actin filaments, presumably 
to preserve energy in the cell to counteract the external nutrient depleted condition. Secretory 
vesicles, marked by GFP-Sec4 were immediately decoupled from the Myo2 tail and became 
cytoplasmic upon glucose depletion (Xu and Bretscher, 2014). Taking advantage of such 
phenotype, I looked at Myo2 and Sec4 phenotype upon glucose depletion in overexpressed 
Smy1 condition.  
 
Interestingly, I found that secretory vesicles stayed together with the Myo2 in Smy1 
overexpressed condition, indicating that Smy1 indeed stabilized the interaction between Myo2 
and Sec4 (Figure 4.3A). Co-imaging the Myo2-3mCherry and GFP-Sec4 showed that Myo2 and 
secretory vesicles were seen along the supposedly actin filaments for about 2 minutes 
compared to wild-type cell (Figure 4.3B). This result supported our hypothesis that Smy1 
stabilized the Myo2 coupling with secretory vesicles. However, the result was not published 
due to its technical novelty and being a separate research area of Myo2 rigor condition.  
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Figure 4.3 Myo2 and Sec4 stays together after glucose depletion in overexpressed Smy1 condition.
A
B
Figure 4.3 Myo2 and Sec4 stays together after glucose depletion in overexpressed Smy1 condition.
(A) Myo2-3GFP and GFP-Sec4 phenotypes after glucose depletion on different smy1 backgrounds.
(B) Co-imaging of Myo2 and Sec4 on overexpressed Smy1 condition.
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Gym1 minimally suppresses sec4-8  
  
 As previously described in Chapter III, a novel Rho GAP Gym1 was involved in the 
secretory vesicle transport. By stimulating the Rho3 GTPase catalytic activity, Gym1 was able 
to suppress myo2 smy1 mutants. To characterize which steps of the secretory pathway Gym1 
was involved, I sought to take advantage of all the conditional mutants available in our lab, i.e., 
sec23-1 – the mutant defective in the early secretory stage, and sec15-1 – the mutant defective in 
the late secretory vesicle fusion at the plasma membrane. Overexpression of the Gym1 
minimally suppressed the sec4-8 (Figure 4.4A). “Minimally” suggests that when I repeated the 
overexpression suppression of Gym1 on sec4-8, I found that the suppression of Gym1 was 
minimal compared to control vector. The original strain we received from the Peter Novick lab 
(ID:ABY127 or NY405) was very sick at 32˚C. Overexpression of Gym1 suppresses sec4-8 (NY) 
minimally (Figure 4.4B). Similarly, when I created sec4-8 in BY background, I found the 
temperature sensitivity of sec4-8 allele alleviated and it only became sick at 35˚C. 
Overexpression of Gym1 suppressed sec4-8 (BY) minimally (Figure 4.4B). Whether or not 
Gym1 required additional suppressors to fully suppress the sec4-8 would be interesting. I also 
tested the genetic interaction between gym1Δ and all conditional mutants such as myo2-66, sec2-
41, and sec4-8 to characterize any genetic interplay in the secretory pathway (Figure 4.4C). 
Unfortunately I did not find any synthetic lethality between gym1Δ and all mutants because all 
double mutants or double nulls are viable.  
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